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Plasma fibronectin is a glycoprotein that consists of two
polypeptide chains of approximately 250,000 and 245,000 daltons,
joined by disulfide bonds located near one end of the molecule.
Fibronectin was isolated from human plasma by gelatin-agarose
affinity chromatography and DEAE-cellulose ion exchange chromato­
graphy. The two subunit chains were found to be similar or
identical with respect to primary structure, using a one-dimensional
peptide mapping technique.
Purified plasma fibronectin was cleaved with human a-thrombin,
and three major fragments were recovered: two large ones with
molecular weights of approximately 230,000 and 235,000, and a small
one with a molecular weight of 29,000. All three fragments appeared
to consist of single polypeptide chains. The fragments were separated
on a column of gelatin-agarose. The smaller piece was not retained,
whereas the larger fragments and remaining undigested molecules were
bound and could be eluted with 2 M guanidine Hel. NH2-terminal
analysis was performed on intact plasma fibronectin and on the
fragments using the dansyl (5-dimethylaminonaphthalene-I-sulfonyl)
chloride technique. No NH2-terminal residue was detected in either
the intact molecule or the small fragment, whereas analysis of the
large fragments yielded dansyl-alanine. Treatment of the intact
molecule and the small fragment with L-pyroglutamyl-peptide hydrolase
resulted in the appearance of NH2-terminal alanine. These results were
confirmed by automated amino acid sequence analysis, which demonstrated
viii
 
that the intact molecule and the 29,000 dalton fragment contained
the same NH2-terminal sequence, <Glu-Ala-Glx-Glx-Met-Val-. Analysis
of the large fragments gave the sequence Ala-Ala-Val-Tyr�. These
studies indicate that the small fragment is located at the NH2-
terminus of intact plasma fibronectin, whereas the large fragments
constitute the carboxyl portion of the molecule. Analysis of
fibronectin isolated from the conditioned medium of human embryonic
fibroblast cultures yielded similar results.
A 72,000 dalton, gelatin-binding polypeptide was isolated from
cathepsin D digests of plasma fibronectin. This fragment was cleaved
further with thrombin to produce a 43,000 dalton fragment which
retained the ability to bind to gelatin and a 29,000 dalton fragment
which did not. NH2-terminal analysis of the 72,000 dalton and 29,000
dalton fragments by the dansyl chloride method before and after
treatment with L-pyroglutamyl-peptide hydrolase indicated that they
shared the same NH2-terminal sequence, <Glu-Ala-, as intact fibronectin.
Automated amino acid sequence analysis of the 72,000 dalton piece
confirmed that the first six NH2-terminal residues of this fragment
were identical with those of the intact molecule. The 43,000 dalton
fragment contained an NH2-terminal alanine residue, as monitored by
dansylation. These findings indicate that the 43,000 dalton fragment,
which contains one or more gelatin-binding sites of plasma fibronectin,
is located adjacent to the 29,000 dalton NH2-terminal region. Both
the 29,000 dalton and 43,000 dalton fragments are enriched in cysteine
and half-cystine, as demonstrated by amino acid analysis.
ix
 
The results of this thesis research can be combined with data
of other investigators to locate several sites of biological
interest within the fibronectin molecule, including binding sites





Discovery of fibronectin - Fibronectin is a term that denotes at
least two closely related glycoproteins found in the tissues of
vertebrates. One form is insoluble and is associated with tissue
stroma; the other form is soluble and is found in blood plasma.
Fibronectin first became an object of intensive study around 1973,
when several laboratories, using immunological or radiochemical
techniques to specifically label proteins on outer cell surfaces,
discovered a major, high molecular weight glycoprotein which was present
on normal fibroblasts but absent on their transformed counterparts
(Gahmberg and Hakomori, 1973; Hynes, 1973; Hogg, 1974; Stone et al.,
1974; Vaheri and Ruoslahti, 1974). An immunologically indistinguishable
protein was detected in blood plasma (Ruoslahti et al., 1973; Ruoslahti
and Vaheri, 1974), and it was soon realized that this protein had been
known to hematologists for nearly thirty years as "cold-insoluble
globulin" (Horrison et al., 1948; Ruoslahti and Vaheri, 1975).
It is only recently that the term "fibronectin" has gained
widespread acceptance; both plasma and cellular forms of the molecule
have been referred to previously by a number of different names. The
cellular form has been called large, external, transformation-sensitive
(LETS) protein (Hynes and Bye, 1974), cell surface protein (CSP) (Yamada
and Weston, 1974), and fibroblast surface antigen (SFA) (Ruoslahti � al.,
1973). The plasma form has been known as cell adhesion factor (CAF)
(Pearlstein, 1976), collagen-cell attachment protein (c-CAP) (Klebe et al.,
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1977), opsonic protein (Allen et al., 1973), and as mentioned,
cold-insoluble globulin (CIg) (Morrison et al., 1948).
The literature on fibronectin is vast, and this introduction
is intended only to provide a background for discussion of the
thesis research. For more comprehensive summaries of the structure
and function of fibronectin, the reader is referred to several
recent review articles (Vaheri and Mosher, 1978; Yamada and Olden,
1978; Mosher, 1980).
Distribution - Fibronectin is found in vivo distributed
---
throughout the body tissues, and it is synthesized and secreted by
a number of cell types in vitro as well. Immunofluorescent studies
of normal adult human tissues show that fibronectin is a component of
most basement membranes, including those which underlie the vascular
endothelium (Stenman and Vaheri, 1978). It is found as a coating
around smooth muscle cells and in the endomysium of striated muscle
fibers, as thin strands in loose connective tissue, and as networks
and fibrils in the stroma of lymphatic tissue (Stenman and Vaheri,
1978). Fibronectin is present in body fluids as well, including
blood plasma (Ruoslahti et al., 1973; Ruoslahti and Vaheri, 1974),
amniotic fluid (Crouch et al., 1978), and cerebrospinal fluid
(�uusela et al., 1978), and it is associated with blood platelets
(Bensusan et al., 1978; Zucker et al., 1979). In the rat embryo,
fibronectin can be detected within the inner cell mass of the
blastocyst as early as the third day of development (Zetter and
Martin, 1978). In developing chicken embryos, fibronectin is present
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in primitive, mesenchymal tissues, but is lost as these differentiate
into more specialized structures (Linder et a1., 1975).
Fibronectin is the major surface glycoprotein of early-passage
cultured fibroblasts and constitutes one to three percent of the
total protein of these cells (Yamada et a1., 1977b). It is also
synthesized by cultured glial cells (Vaheri et a1., 1976), endothelial
cells (Birdwell et al., 1978; Jaffe and Mosher, 1978), and some other
epithelial cell types (L. B. Chen et al., 1977a; Crouch � al., 1978;
Quaroni et a1., 1978). As fibroblasts attach to a surface and begin
to spread, fibronectin is first detected as spots at the cell-substrate
interface; at later times, it becomes organized into fibrils (Grinnell
and Feld, 1979). As cultures become densely populated, extensive
three-dimensional pericellular and intercellular lattices of fibronectin
are formed (Bornstein and Ash, 1977; L.B. Chen et a1., 1978; Vaheri
et a1., 1978); these are only loosely associated with the cell membrane
(Graham et a1., 1975; L.B. Chen et a1., 1978). In cultures of other
cell types, the pattern of distribution of extracellular fibronectin
may vary (L.B. Chen et al., 1977a; Mosher et a1., 1977; Birdwell � al.,
1978; Jaffe and Mosher, 1978; Quaroni et al., 1978). Fibronectin also
occurs in a nonfibri11ar, intracellular form (Yamada, 1978) and in a
soluble form which is secreted into the culture medium (Vaheri et a1.,
1976; Mosher et a1., 1977; Olden and Yamada, 1977).
Structural features - Both plasma and cellular fibronectins are
dimers, composed of polypeptide subunits of approximately 220,000
daltons (Mosesson et al., 1975; Hynes and Destree, 1977; Keski-Oja
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et al., 1977). Proteolytic digestion of these proteins suggests that
the interchain disulfide bonds which join the monomers lie within a
10,000 to 30,000 dalton region located at one end of the molecule
(A.B. Chen et al., 1977; Jilek and Hormann, 1977a; Wagner and Hynes,
1979). Fibronectin in the extracellular matrix is also found as part
of high molecular weight complexes (Hynes and Destree, 1977; Keski-Oja
et al., 1977), the components of which have not yet been fully
characterized. The NH2-termini of bovine and human plasma fibronectin
are blocked with pyroglutamic acid; treatment with L-pyroglutamyl­
peptide hydrolase results in the appearance of NH2-terminal alanine
(Mosesson et al., 1975; Iwanaga et al., 1978). Fibronectin isolated
from chick cells also has a blocked NH2-terminus; however, attempts to
remove the blocking residue with L-pyroglutamyl-peptide hydrolase were
unsuccessful (Yamada et al., 1977a). Amino acid compositions of
cellular and plasma fibronectins isolated from several different
species are very similar to one another and show no unusual features
(Vuento et al., 1977; Yamada et al., 1977a; Carter et al., 1978; Iwanaga
et al., 1978). Antisera to human plasma fibronectin cross-react with
plasma and cellular fibronectins from several other mammalian species
and from chicken (Kuusela et al., 1976); this result suggests that
fibronectin has been highly conserved during evolution.
Cellular and plasma fibronectins are both glycoproteins with
similar carbohydrate content (four to five percent) and composition
(Vuento et al., 1977). Both forms contain one mole of cysteine per
subunit chain (Wagner and Hynes, 1979), and it has been speculated that
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these residues may be important in the formation of the high molecular
weight, fibronectin-containing complexes that are found in extracellular
matrices (Wagner and Hynes, 1979). Cellular fibronectin is both sulfated
(Dunham and Hynes, 1978) and phosphorylated (Teng and Rifkin, 1979).
Fibronectin secreted by normal chicken embryo fibroblasts contains
approximately one mole of phosphate per subunit chain, whereas fibronectin
secreted by transformed chicken fibroblasts contains only about one-half
of this amount (Teng and Rifkin, 1979).
The physical characteristics of fibronectins isolated from human
plasma (Alexander et al., 1979) and from surfaces of chicken fibroblasts
(Alexander et al., 1978) have been examined by velocity centrifugation,
circular dichroism, and fluorescence spectroscopy under various conditions.
Both proteins appear to have a similar, asymmetric tertiary structure,
consisting of organized domains connected by random polypeptide chains.
The molecules thus have high frictional ratios and considerable flexibility.
Although the studies summarized above indicate that plasma and
cellular fibronectins are extremely similar, some differences have been
noted. Fibronectin isolated from cell surfaces is considerably less
soluble at physiological ionic strength and pH than the plasma form
(Yamada and Kennedy, 1979) and, as will be discussed, is more active in
certain biological assay systems (Yamada and Kennedy, 1979). Several
groups report that fibronectin isolated from cell surfaces and fibronectin
secreted into culture media have subunits which migrate identically on
SDS-polyacrylamide gels; however, their subunits have a slightly larger
apparent molecular weight than those of plasma fibronectin isolated from
the same species (Crouch et al., 1978; Quaroni et al., 1978; Yamada and
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Kennedy, 1979). Other laboratories report that subunits of plasma
and cellular fibronectins have the same mobility (Vuento et al.,
1977; Jaffe and Mosher, 1978). Clearly, further work is needed to
resolve these discrepancies.
The physical or chemical bases for the observed differences
between cellular and plasma fibronectins are uncertain. Some
dissimilarities in glycosylation have been reported. For example,
human plasma fibronectin contains slightly more sialic acid than
fibronectin secreted by human fibroblasts does (Vuento et al., 1977).
Detailed structural analyses of the carbohydrate chains of hamster
cellular fibronectin (Carter and Hakomori, 1979; Fukuda and Hakomori,
1979) and bovine (Takasaki et al., 1979) and human (Wrann, 1978)
plasma fibronectins reveal some differences; however, direct
comparisons of cellular and plasma fibronectins derived from a single
species have not been made. It has been suggested that fibronectin
isolated from cell surfaces is less soluble and more active in some
assays than plasma fibronectin because it exists largely in a
multimeric, multivalent state (Mosher, 1980). Further comparisons of
plasma fibronectin, fibronectin secreted by cells, and fibronectin
extracted from cell surfaces, with special regard to the degree of
aggregation of each preparation, will be useful in testing this
hypothesis. Comparisons of the fibronectins produced by different
cell types may also aid in identifying the source or sources of
plasma fibronectin, which are presently unknown.
Biological activities - Although the primary biological roles of
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fibronectin are unclear, both the plasma and cell surface molecules
are involved in a number of processes where they function in an
adhesive or binding capacity. Plasma fibronectin mediates the
adhesion and spreading of some cell types on plastic tissue culture
dishes (Grinnell and Hays, 1978; Hughes et al., 1979) and on surfaces
which have been coated with dried collagen films (Klebe, 1974;·
Pearlstein, 1976). Plasma fibronectin markedly enhances adhesion of
baby hamster kidney cells to denatured collagen substrates (Pearlstein,
1976; Grinnell and Minter, 1978); however, it is not required for
their attachment and spreading on native collagen gels (Grinnell and
Minter, 1978). Plasma fibronectin also promotes the spreading of
platelets on collagen surfaces, although it is not necessary for their
initial attachment (Hynes et al., 1978).
In addition to its role as a cell adhesion factor, plasma
fibronectin has been demonstrated to be identical with u2-surface
binding glycoprotein (Blumenstock et al., 1978b), a serum component
which binds to gelatinized lipid emulsions and potentiates their
clearance from the blood by the reticuloendothelial system (Allen
et al., 1973; Blumenstock et al., 1978a). Some septic surgical and
trauma patients have impaired reticuloendothelial system function and
abnormally low levels of circulating plasma fibronectin (Saba et al.,
1978). In one study, infusion of three such patients with fibronectin­
containing cryoprecipitate was associated with improved pulmonary
function and lowering of elevated body temperature (Saba et al., 1978).
Furthermore, fibronectin promotes binding of fibrin monomer to
macrophages (Jilek and Hormann, 1978b). Macrophages also specifically
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bind denatured, but not native, collagen; uptake is mediated by a
high molecular weight, gelatin-binding serum component which is
probably identical with fibronectin (Hopper et al., 1976). These
results indicate that plasma fibronectin may function in vivo as an
opsonic protein which promotes removal of debris from the circulation
following tissue injury.
Like plasma fibronectin, cellular fibronectin mediates
attachment of some cell types to denatured collagen films (Pearlstein,
1976). Some cell strains do not require addition of fibronectin for
substrate adhesion; however, studies indicate that endogenous, secreted
fibronectin plays a role in their attachment and spreading (Grinnell
and Feld, 1979). Fibronectin extracted from chicken embryo fibroblasts
agglutinates formalinized sheep erythrocytes (Yamada et al., 1975) and
promotes aggregation of living mammalian and chicken cells in
suspension (Yamada et al., 1978). Fibronectin extracted from cell
layers or secreted into the medium enhances the motility of both
normal and transformed cells (Ali and Hynes, 1978), possibly by
providing cell-substrate anchorage sites.
As mentioned, fibronectin is present in greatly reduced amounts
on the surfaces of many transformed cells (Gahmberg and Hakomori, 1973;
Hynes, 1973; Hogg, 1974; Stone et al., 1974; Vaheri and Ruoslahti, 1974).
The addition of fibronectin extracted from monolayers of normal cells to
such transformed cultures causes them to assume a more normal morphology.
The cells adhere more tightly to the substrate, become more spread out
and elongated, and become more aligned with one another (Yamada et al.,
1976b; Ali et al., 1977). Exogenous cell surface fibronectin also
decreases the number of plasma membrane microvilli, blebs, and ruffles
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(Yamada et al., 1976a) and restores ordered actin microfilament
bundles (Ali et al., 1977; Willingham et al., 1977). Added cellular
fibronectin does not affect a number of other properties of transformed
cells, including rate of division: and saturation density (Yamada et al.,
1976b), rates of sugar (Ali et al., 1977; Willingham et al., 1977) and
amino acid (Willingham et al., 1977) transport, and levels of cAMP
(Yamada et al., 1976b). It is possible, then, that all of the effects
that exogenously supplied cell surface fibronectin exerts on transformed
cells arise from its ability to increase adhesion between cell and
substrate.
The various forms of fibronectin differ in activity when tested in
some of these in vitro systems. Fibronectins extracted from cell layers,
secreted by cells, and isolated from plasma are all equally capable of
mediating cell attachment and spreading on collagen (Pearlstein, 1976;
Pena and Hughes, 1978; Yamada and Kennedy, 1979). However, plasma
fibronectin is one hundred fifty-fold less active than fibronectin
extracted from cell layers in hemagglutination assays, and fifty-fold
less active in restoring a more normal appearance to transformed cells
(Yamada and Kennedy, 1979). As has been discussed, these differences
possibly reflect the proportion of molecules in each preparation which
are in an aggregated, multivalent state (Mosher, 1980). That the
morphology of transformed cells is unaffected by their co-cultivation
with normal cells (L.B. Chen � al., 1977b) might be explained
similarly; that is, the fibronectin secreted by the normal cells may
not be in the proper multimeric state to effectively reconstitute a
matrix. However, there is at least one report that fibronectin isolated
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from conditioned media is as effective in inducing changes in
transformed cells as fibronectin extracted from cell layers (Ali � al.,
1977). Studies that relate the activites of various fibronectin
preparations to their physical state will be required to clarify this
point.
Interactions with other macromolecules - Presumably, plasma and
cellular fibronectins function in vivo as bridging, adhesive elements
by binding to other macromolecules, and indeed, a number of interactions
of potential biological interest have been demonstrated in vitro. Both
forms of fibronectin have strong affinities for collagen when tested in
a variety of assay systems (Engvall and Ruoslahti, 1977; Dessau et al.,
1978; Engvall et al., 1978; Jilek and Hormann, 1978a). In most of these
systems, binding of fibronectin to denatured collagen (gelatin) is
considerably stronger than to the native molecule (Engvall and Ruoslahti,
1977; Engvall et al., 1978; Jilek and Hormann, 1978a); differences in
affinities of one hundred-fold and more have been reported (Engvall and
Ruoslahti, 1977; Engvall et al., 1978). Fibronectin interacts with both
interstitial (Types I, II, and III) (Engvall and Ruoslahti, 1977; Dessau
� al., 1978; Engvall et al., 1978; Jilek and Hormann, 1978a) and
basement membrane (Types IV and AB) (Dessau � al., 1978; Engvall � al.,
1978) collagens. In some assays, differences in affinities of fibronectin
for the various types of native collagen are detected; binding to native
Type III collagen is strongest (Engvall et al., 1978; Jilek and Hormann,
1978a).
Fibronectin binds most strongly to cyanogen bromide peptide 7 of
the a1 (I) collagen chain (Kleinman et al., 1976; Dessau et al., 1978) and
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to homologous peptides derived from the a1 (II) chain (Kleinman � al.,
1976; Dessau et al., 1978) and the a2 chain (Dessau et al., 1978).
Further digestion of cyanogen bromide peptide 7 with proteases has more
precisely located the binding site of fibronectin within residues 757
to 791 of the a1 (I) chain (Kleinman et al., 1978), a region that also
contains the peptide bond cleaved by animal collagenases (Gross et al.,
1974). However, fibronectin also interacts with other collagen fragments
(Kleinman et al., 1976; Dessau et al., 1978; Engvall et al., 1978),
suggesting that collagen may contain several binding sites for fibronectin.
In addition to directly binding to collagen, plasma fibronectin can
be covalently cross-linked to Types I and III collagens by plasma
transglutaminase (coagulation factor XIII) (Mosher et al., 1979). Cross-
a --
o
linking to intact collagen does not occur at temperatures lower than 37 C,
indicating that some local denaturation may be required to expose active
residues on the collagen molecule. As has been discussed, fibronectin
also mediates attachment of cells to denatured collagen (Klebe, 1974;
Pearlstein, 1976; Hynes et al., 1978), increases opsonization of
gelatinized particles (Allen et al., 1973; Blumenstock et al., 1978), and
may promote binding of denatured collagen to macrophages (Hopper � al.,
1976). Furthermore, there is an extensive codistribution of fibronectin
and collagen in the extracellular matrices of normal fibroblasts, and
both proteins are lost upon transformation (Vaheri � al., 1978).
It has long been known that plasma fibronectin has a tendency to
coprecipitate with fibrin and fibrinogen in the cold (Morrison e� al.,
1948). Plasma fibronectin and fibrinogen are the major components of
plasma cryoprecipitate (Mosesson and Umfleet, 1970), and fibronectin,
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fibrinogen, and fibrin constitute the pathologic plasma precipitates
termed "cryofibrinogens" (Stathakis et aI., 1978). Plasma fibronectin
is included in fibrin clots, particularly those formed at OOC, and is
adsorbed to fibrin powder in the cold (Ruoslahti and Vaheri, 1975).
It also has an affinity for fibrin-Sepharose at low temperatures
(Sternberger and Hormann, 1976; Stathakis et al., 1978), but there are
conflicting reports with regard to its affinity for fibrinogen-Sepharose
(Ruoslahti and Vaheri, 1975; Sternberger and Hormann, 1976; Stathakis
et al., 1978). Binding of fibronectin to fibrin is stronger than
binding to fibrinogen (Sternberger and Hormann, 1976; Stathakis et al.,
1978). The presence of the carboxyl region of the a-chain of fibrin
and fibrinogen is essential for interaction with fibronectin (Stathakis
and Mosesson, 1977; Stathakis et al., 1978). Plasma fibronectin also
enhances binding of fibrin monomer to macrophages (Jilek and Hormann,
1978b). Although plasma fibronectin can be cross-linked by plasma
transglutaminase to the a-chain of fibrin (Mosher, 1975), cellular
fibronectin cannot (Keski-Oja et al., 1976).
Plasma transglutaminase not only cross-links plasma fibronectin to
collagen (�osher et al., 1979) and fibrin (Mosher, 1975), but also, in
the presence of reducing agent, to other fibronectin molecules (Mosher,
1975). Plasma fibronectin is also polymerized by a cellular trans­
glutaminase isolated from guinea pig liver (Birckbichler and Patterson,
1978). Experiments using (14C)putrescine show that there is probably
one transamidation-sensitive glutaminyl residue per 220,000 dalton
plasma fibronectin chain (Jilek and Hormann, 1977b). Treatment of
fibroblast cultures with plasma transglutaminase results in the cross-
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linking of cell surface fibronectin to a high molecular weight complex
(Keski-Oja et al., 1976). The components of this complex have not
yet been analyzed; cell surface fibronectin might be cross-linked to
itself or to other matrix proteins.
Interactions of fibronectin with glycosaminoglycans and
proteoglycans have also been demonstrated. Addition of the anti­
coagulant glycosaminoglycan heparin to plasma results in the formation
of a cold-precipitable complex composed primarily of plasma fibronectin,
fibrinogen, and heparin, and it has been shown that it is the plasma
fibronectin which first associates with heparin (Stathakis and Mosesson,
1977). Presumably, fibrinogen is included in this complex by virtue of
its affinity for fibronectin. Heparin also enhances the formation of
insoluble complexes of plasma fibronectin and native Type III or denatured
Types I and III collagens (Jilek and H�rmann, 1979); hyaluronic acid
inhibits this complex formation (Jilek and H�rmann, 1979). Fibronectin
secreted by fibroblasts has been coupled to photoactivatable chemical
cross-linking agents and added back to cell cultures; following exposure
of the cultures to ultraviolet light, complexes of fibronectin and sulfated
proteoglycans can be isolated from the cell surface (Perkins et al., 1979).
Immunofluorescent staining of cultured cells indicates that arrays
of extracellular fibronectin fibrils and intracellular actin microfilaments
often coincide (Hynes and Destree, 1978). Electron microscopic studies
suggest that fibronectin fibrils and microfilaments may be connected
within dense plaques located just beneath the plasma membrane (Singer,
1979). Furthermore, there is a preliminary report that plasma fibronectin
and fibronectin secreted by cells bind to immobilized actin (Keski-Oja
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et al., 1979). Fibronectin may also interact with DNA. Fibronectin is
present in chromatin prepared from cultured human fibroblasts (Zardi et
al., 1979). It has been reported that plasma fibronectin binds to
DNA-cellulose (Zardi et al., 1979), but not to DNA-Sepharose (Keski-Oja
et al., 1979). However, since fibronectin has not been detected in the
nucleus by immunofluorescent staining (Yamada, 1978), the in vivo
relevance of its association with DNA is unclear.
Fibronectin-mediated cell attachment to collagen is inhibited by a
number of gangliosides isolated from brain, especially GT1 and GD1a
(Kleinman et al., 1979). Oligosaccharide chains isolated from gangliosides
retain inhibitory activity, whereas the ceramide portions alone do not
(Kleinman et al., 1979). These results suggest that gangliosides or other
macromolecules containing similar carbohydrate moieties may represent
cellular receptors for fibronectin.
Fibronectin thus interacts with a wide variety of different macro-
molecules in vitro. These associations could be important in a number
of in vivo processes. For example, fibronectin might playa role in the
organization of extracellular ground substance and basement membranes,
mediate adhesion and migration of cells during embryogenesis and wound
repair, aid in formation of platelet-fibrin plugs following vascular
injury, and enhance clearance of tissue debris from the blood. Clearly,
the possible biological functions of fibronectin merit further study.
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Aim of the thesis research - At the time this thesis research was
undertaken, relatively little was known about the physical and chemical
properties of fibronectin. Therefore, it was decided to focus these
studies on the structure of fibronectin rather than on its biological
characteristics. It was hoped that a fuller understanding of its
structural properties would eventually lead to a more detailed picture
of the ways in which fibronectin acts as a bridge between macromolecules
and between cells and their environment. One impediment to studying
fibronectin structure is the extremely large size of the molecule. The
approach taken, therefore, was to cleave the molecule with proteases, to
isolate and characterize some of the fragments produced, and finally,
to locate the fragments within the intact molecule. In this way, it
might be possible to construct a map of the molecule relating structure
to some of fibronectin's functions, including binding to other macro­
molecules. The remainder of this thesis will be largely devoted to






Purified human a-thrombin (>2300 NIH units/mg) was a gift from Dr.
J. W. Fenton II, New York State Department of Health, Albany, New York.
Rabbit skeletal muscle myosin was provided by Dr. Richard Peluso,
Veterans Administration Hospital, San Francisco, California. Pepstatin
was a gift from Dr. Walter Troll, New York University Medical Center,
New York, New York, and was supplied by the United States-Japan
Cooperative Cancer Research Program. Fresh-frozen acid citrate dextrose
human plasma was obtained from the Greater New York Blood Program. Dansyl
chloride (1 g/lO ml of acetone), constant-boiling HCI (Sequenal grade),
dithiothreitol, and Schleicher and Schuell micropolyamide sheets with
aluminum foil support base were all purchased from Pierce Chemical Co.
SDS was a specially pure grade manufactured by BDH Chemicals, LTD, Poole,
England, and distributed by Gallard-Schlesinger Chemical Mfg. Corp.
Other products were obtained from the following sources: PhCH2S02F,
benzamidine HCI, and 6-aminocaproic acid, Adrich Chemical Co., Inc.;
DEAE-cellulose (DE52) and phosphocellulose (Pll), Whatman, Inc.; acryl­
amide (electrophoresis grade) and N, N'-methylene-bis-acrylamide, Eastman
Kodak Co.; soybean trypsin inhibitor, bovine serum albumin, and
Staphylococcus aureus V8 protease, Miles Laboratories, Inc.; Sepharose
CL-4B, Sephadex G-150, ovalbumin, ribonuclease, and chymotrypsinogen,
Pharmacia Fine Chemicals; S-galactosidase, Worthington Biochemical Corp.;
cathepsin D (EC 3.4.23.5), gelatin (Type I: 300 bloom), dansyl-amino acid
standards, and hirudin (Grade IV), Sigma Chemical Co.; guanidine HCI
(extreme purity), Heico, Inc., Delaware Water Gap, Pennsylvania;
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(NH4)2S04 (ultra-pure), Schwarz/Mann; L-pyroglutamyl-peptide hydrolase
(EC 3.4.11.8), Boehringer Mannheim Biochemicals; streptokinase­
streptodornase (Varidase), Lederle Laboratories; L-pyroglutamyl-L-alanine,
Vega-Fox Biochemicals, Tucson, Arizona; Trasylol, FBA Pharmaceuticals,
New York, New York; 1251 (carrier-free, 17 Ci/mg), New England Nuclear;
plastic tissue culture roller bottles (490 cm2), Corning Glass Works;
Eagle's medium and calf serum, Flow Laboratories; fetal calf serum,
Reheis Chemical Co.; Fungizone, E. R. Squibb and Sons; and incomplete
and complete Freund's adjuvant, Grand Island Biological Co. All other




Purification of human plasma fibronectin - Four to five units of
fresh-frozen, acid citrate dextrose plasma were thawed at 370C and
pooled, and soybean trypsin inhibitor (100 mg/liter) was added.
Vitamin K-dependent clotting factors were removed by the addition of
BaC12 (15 g/liter) (Aronson and Menache, 1966); the resulting suspension
o
was stirred gently at 0 C for 30 min. The precipitate, consisting of
barium citrate and adsorbed protein, was removed by centrifugation at
o
5000 x £ for 20 min at 4 C. Excess barium was precipitated from the
supernatant by adding (NH4)2S04 (9.5 g/liter), followed by centrifugation
as above (A.B. Chen and Mosesson, 1977). PhCH2S02F was added to the
plasma to a final concentration of' 1 mM. The plasma was passed over a
180 ml column (4.0 x 14 cm) of lysine-Sepharose CL-48 (Deutsch and
Mertz, 1970) equilibrated at 40C with PBS containing soybean trypsin
inhibitor (100 mg/liter) and 1 mM PhCH2S02F. The rate of flow was
approximately 200 ml/h. The effluent was collected into a beaker
containing sufficient benzamidine HCl to bring the final concentration
to approximately 3 mM.
Plasma fibronectin was removed from the plasminogen-depleted
plasma by adsorption to a gelatin-agarose column as described by
Engvall and Ruoslahti (1977). The plasma was passed over a 100 ml
column (2.5 x 20 cm) of gelatin-Sepharose CL-4B equilibrated with PBS
containing 3 mM benzamidine HCl and 1 mM PhCH2S02F. The rate of flow
was 100 to 150 ml/h, and chromatography was carried out at room
temperature. The column was washed with 1 liter of the buffer used
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for equilibration, followed by 500 ml of 0.5 M guanidine HCl, 0.05 M
Hepes, 3 roM benzamidine HCl, pH 7.5. Plasma fibronectin was eluted
with 1.0 M guanidine HCl, 0.05 M Hepes, 3 roM benzamidine HCl, pH 7.5.
Fractions of 5 ml were collected, and the concentration of protein
in the effluent was monitored by absorption at 280 nm. Protein­
containing fractions were pooled and dialyzed against 0.2 M
phosphate-Tris, 3 roM benzamidine HCl, pH 7.0, at room temperature.
Plasma fibronectin was further purified by ion-exchange
chromatography on DEAE-cellulose according to Mosesson and Umfleet
(1970). The dialyzed sample was diluted with three volumes of 3 roM
benzamidine HCl in water and applied at a rate of 120 ml/h to a 55 ml
column (2.0 x 18 cm) of DEAE-cellulose equilibrated with 0.05 M
phosphate-Tris, pH 7.0. Chromatography was carried out at room
temperature. The column was washed with approximately 75 ml of 0.05
M phosphate-Tris, pH 7.0, and 200 ml of 0.09 M phosphate-Tris, pH 7.0.
Plasma fibronectin was eluted with 0.2 M phosphate-Tris, pH 7.0.
Fractions of 5 ml were collected. Material representing the peak of
absorbance at 280 nm was pooled and dialyzed against PBS at 4°C. Any
precipitate formed during dialysis was redissolved by warming the
plasma fibronectin solution to 37oC. Aliquots were then frozen in a
dry ice-methanol bath and stored at -70oC.
Purification of human cellular fibronectin - Fibronectin was
isolated from the conditioned medium of human embryonic fibroblasts by
a modification of the method of Teng and Rifkin (1979). Tertiary




plastic roller bottles (490 cm ), and grown to confluency at 37 C in
Eagle's medium containing 10% fetal calf serum. For preparation of
conditioned medium, -cultures were maintained in Eagle's medium
containing soybean trypsin inhibitor (100 �g/ml), 6-aminocaproic acid
(500 �g/ml), Fungizone (1 �g/ml), and 2% calf serum which had been
depleted of plasminogen (Deutsch and Mertz, 1970) and fibronectin
(Engvall and Rouslahti, 1977) by affinity chromatography. Spent medium
o
was collected every 48 h, centrifuged at 5000 x � and 4 C for 20 min to
remove cell debris, and stored at -200C.
To isolate fibronectin, conditioned media were pooled and made
0.5 M in guanidine HCI, 5 rnM in Na2EDTA, and 3 rnM in benzamidine HCI.
Gelatin-Sepharose (1 ml of Sepharose/l00 ml of medium) was added, and
the suspension was gently stirred overnight at 40C. The Sepharose was
allowed to settle, the bulk of the medium was decanted, and the remaining
slurry was poured into a glass column. The packed gelatin-Sepharose was
washed extensively with 0.05 M Hepes, 5 rnM Na2EDTA, 3 rnM benzamidine
HCI, pH 7.5, containing 0.5 M guanidine HCI. Fibronectin was subsequently
eluted with this same buffer containing 1.5 M guanidine HCI. All
chromatographic steps were performed at room temperature. Fractions
representing the peak of absorbance at 280 nm were pooled and dialyzed
against PBS supplemented with additional NaCI (17.5 g/liter) and made
5 rnM in Na2EDTA and 3 rnM in benzamidine HCI. Purified material was
� -
stored at 4 C in the presence of 0.02% NaN3.
SDS-polyacrylamide gel electrophoresis - Polyacrylamide gel
electrophoresis in the presence of SDS was performed in a slab gel
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apparatus (Studier, 1973), using the discontinuous buffer system
described by Laemmli (1970). Separating gels consisted of linear 5
to 16% acrylamide gradients; stacking gels were 3% acrylamide.
o
Protein samples were prepared by heating them at 100 C for 2 min in
0.0625 M Tris-HCl, 10% glycerol, 2% SDS, 0.001% Bromphenol Blue,
pH 6.8, with or without the addition of 2-mercaptoethanol to 5%.
The following proteins were used as molecular weight standards:
myosin (M =200,000), S-galactosidase (M =130,000), bovine serum-r -r
albumin (M =68,000), ovalbumin (M =43,000), chymotrypsinogen-r -r
(M =25,700), and ribonuclease (M =13,700). Gels were fixed and-r -r
stained as described by Fairbanks et al. (1971) and, in some cases,
were scanned using an Ortec model 4310 densitometer.
Peptide mapping of plasma fibronectin subunits - One-dimensional
peptide mapping by limited proteolysis in SDS-polyacrylamide gels was
performed according to Cleveland et al. (1977). Samples of purified
plasma fibronectin were iodinated by the chloramine-T method
(McConahey and Dixon, 1966) and electrophoresed on an SDS-polyacrylamide
gel in the usual manner. The gel was stained and destained only briefly
to avoid acid hydrolysis of the protein. Protein bands were cut from
the gel, soaked for 30 min in 0.125 M Tris-HCl, 0.1% SDS, 1 mM Na2EDTA,
pH 6.8, trimmed, and placed at the bottoms of the sample wells of a
second SDS-polyacrylamide gel. This gel was also prepared in the
normal manner, except that the stacking gel was longer than usual, and
Na2EDTA was added to the polyacrylamide solutions to a final
concentration of 1 mM prior to polymerization. The separating gel
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consisted of a linear 8 to 18% acrylamide gradient; the stacking gel
contained 4% acrylamide. The fibronectin-containing slices were
overlaid with 10 pI of 0.125 M Tris-HCl, 0.1% SDS, 1 mM Na2EDTA,
0.001% Bromphenol Blue, pH 6.8, containing 20% glycerol. Next, 10 pI
of this same buffer containing 10% glycerol and an appropriate amount
of Staphylococcus aureus V8 protease were added to each well. Electro­
phoresis was carried out as usual, except that the current was turned
off for 30 min when the Bromphenol Blue neared the bottom of the
stacking gel. Autoradiography of the fixed, dried gel was performed
using DuPont Cronex medical x-ray film.
Digestion of fibronectin with thrombin and separation of fragments -
Purified human a-thrombin (75 pg) was added to 10 mg of plasma
fibronectin in 2 to 3 ml of PBS. The mixture was incubated for 1 h at
37oC. Thrombin was removed by passing the digest over a 0.5 ml column
of phosphocellulose equilibrated with PBS. The digest was then applied
to a 7.5 ml column (1.2 cm x 6.5 cm) of gelatin-Sepharose CL-4B
equilibrated with PBS, and the column was washed with this same buffer.
Both chromatographic steps were performed at room temperature. Fractions
of 0.5 to 1.0 m1 were collected and their protein content determined by
the method of Lowry et al. (1951). A small plasma fibronectin fragment
which was generated was not retained by the gelatin-Sepharose and was
collected in these fractions. When examined by SDS-polyacrylamide gel
electrophoresis, the first several protein-containing fractions were
seen to contain a relatively large proportion of high molecular weight
contaminant fragments and were discarded. The remainder of the protein
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was pooled; solid (NH4)2S04 was then added to 90% saturation at OOC.
The precipitate was collected by centrifugation at 12,000 x £ and
4°C for 30 min, redissolved in a small amount of PBS, and dialyzed
against this buffer at 4°C. The large proteolytically-derived
fragments and remaining intact molecules were eluted from the
column with 2.0 M guanidine HCl, 0.05 M Hepes, pH 7.5, and dialyzed
against PBS at 4°C.
Fibronectin isolated from conditioned media of human embryonic
fibroblast cultures was prepared for digestion as follows. Purified
material was dialyzed against PBS at room temperature; the dialysis
buffer was then changed twice at hourly intervals. Purified human
a-thrombin was added to the dialyzed fibronectin solution (1:100, w/w),
and the mixture was incubated for 1.5 h at 37oC. The digest was then
treated as described above for plasma fibronectin.
Digestion of plasma fibronectin with cathepsin D and separation
of fragments - Cleavage of fibronectin with cathepsin D and isolation
of a collagen-binding fragment were carried out essentially according
to Balian et al. (1979). Fibronectin (8 to 10 mg in 2 ml of PBS) was
diluted with 0.1 M sodium formate, 0.2 roM PhCH2S02F, pH 3.5, to a final
concentration of 200 �g/ml. Cathepsin D (40 �g) was added, and the
mixture was incubated at 300C for 4 h. The reaction was stopped by
the addition of 12 �g of pepstatin, and the solution was brought to
neutrality with 1.5 M Tris-HCl, pH 8.8. Digested protein was
precipitated by the addition of an equal volume of saturated (NH4)2S04
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at OoC and sedimented by centrifugation at 12,000 x £ for 20 min at
4°C. The pellet was resuspended in 1.5 ml of 0.15 M NaCl, 0.05 M
Tris-HCl, 3 mM benzamidine HCl, 0.2 roM PhCH2S02F, pH 7.5. The
suspension was incubated at 370C for 10 to 15 min with occasional
shaking; any undissolved protein was then removed by brief sedimentation
on a clinical centrifuge at room temperature. The supernatant was
applied to a column (1.2 x 95 cm) of Sephadex G-150 equilibrated with
0.15 M NaCl, 0.05 M Tris-HCl, 3 roM benzamidine HCl, 0.2 roM PhCH2S02F,
o
pH 7.5, at 4 C. The column was eluted with this same buffer at a
flow rate of approximately 3 ml/h. Two protein-containing peaks were
seen as monitored by absorbance at 280 nm; material from the more
slowly eluting peak was pooled and stored at -20oC.
A 72,000 dalton gelatin-binding fragment was isolated from this
material by affinity chromatography. Pooled protein solutions were
passed over a column of gelatin-Sepharose equilibrated with 0.15 M
NaCl, 0.05 M Tris-HCl, 3 roM benzamidine Hel, 0.2 roM PhCH2S02F, pH 7.5,
at room temperature. Approximately 0.5 ml of resin was used for
every 5 ml of protein solution. The column was then washed
extensively with the buffer used for equilibration. Gelatin-binding
fragments were eluted with this same buffer containing 2.0 M
guanidine HCl. Protein-containing fractions were pooled, dialyzed
at 40C against 0.15 M NaCl, 0.05 M Tris-HCl, pH 7.5, and stored at
-20oC.
Digestion of the gelatin-binding fragment with thrombin and
separation of fragments - The 72,000 dalton gelatin-binding fragment
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(1.0 mg in 1.0 ml of 0.15 M NaCl, 0.05 M Tris-HCl, pH 7.5) was digested
further with 40 �g of purified human a-thrombin for 7 h at 37oC.
Thrombin was removed from the digest by passage over a column (0.4 ml)
of phosphocellulose equilibrated with PBS at room temperature. The
thrombin-depleted digest was applied to a column (1.0 ml) of gelatin­
Sepharose equilibrated with PBS at room temperature. The column was
washed with PBS, and a 29,000 dalton fragment which was not retained
by the gelatin was collected in the effluent. A 43,000 dalton
gelatin-binding fragment was then eluted from the column with 2.0 M
guanidine HCl in PBS and was dialyzed at 4°C against an appropriate
buffer solution.
Digestion of fibronectin and its fragments with L-pyroglutamyl­
peptide hydrolase - Enzymatic removal of pyroglutamic acid was
performed essentially according to Podell and Abraham (1978). Native
or reduced and alkylated proteins were dialyzed at 40C against buffer
prepared as by Podell and Abraham (1978), but without dithiothreitol.
The buffer was made by bringing 0.1 M Na2HP04 to pH 8.0 with 0.1 M
NaH2P04; this solution was then made 10 mM in Na2EDTA and 5% in glycerol
(v/v), and readjusted to pH 8.0 with 1 N NaOH. The dialyzed protein
solution was made 5 mM in dithiothreitol, and one-tenth as much
lyophilized crude L-pyroglutamyl-peptide hydrolase as protein was added
on a weight basis. After an 8 h incubation at room temperature under
N2, another portion of enzyme equal to the first was added, and
incubation was continued as before for an additional 16 h. The samples
were then made 1% in SDS, heated for 3 min at lOOoC, and dialyzed
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against 0.2 M NaHe03, 1% SDS, pH 8.5, at room temperature in preparation
for dansylation. Alternatively, samples were prepared for automated
sequence analysis by dialysis against 0.2 M ammonium acetate at 4°e and
lyophilization. L-pyroglutamyl-peptide hydrolase activity was quantitated
using L-pyroglutamyl-L-alanine as a substrate (Doolittle, 1972).
NH2-terminal amino acid analysis - A modification of the dansyl
chloride method of Weiner et ale (1972) was used to determine the NH2-
terminal amino acid residues of intact fibronectin and the various
proteolytically-derived fragments. Protein solutions were mixed with
10% SDS (10:1, v/v), immediately heated at 1000e for 3 min, and then
dialyzed against 0.2 M NaHC03, 1% SDS, pH 8.5, at room temperature.
Aliquots (20 to 200 �l) containing 1 to 5 nmol of protein were removed
and mixed with an equal volume of dansyl chloride solution (5 mg/ml
o
of acetone) at 37 e for 2 h. Protein was precipitated by addition of
ice-cold 20% trichloroacetic acid, sedimented in a clinical centrifuge,
and washed once or twice with 200 �l of 1 N HCI. The protein was
hydrolyzed in 100 �l of constant-boiling HCI for 4 to 6 h at 108°C
in sealed tubes. The hydrolysate was dried u�der vacuum and extracted
twice with 100 �l aliquots of water-saturated ethyl acetate (Gray, 1972).
The ethyl acetate extract was dried by heating in an 80?C water bath.
Both ethyl acetate extractable and nonextractable residues were
dissolved in 5 �l of 50% aqueous pyridine and analyzed by thin-layer
chromatography on polyamide sheets (5 x 5 cm) (Woods and Wang, 1967),
using the solvents described by Hartley (1970). The chromatographic
system clearly resolved all components of a standard mixture containing
twenty dansyl-amino acids and dansyl-amide.
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Automated amino acid sequence analysis - Reduced and alkylated,
lyophilized samples were dissolved in 0.5 to 1.0 ml of heptafluorobutyric
acid or 1% SDS and analyzed on a Beckman 890C Sequencer run with a 0.1 M
Quadrol program modified from Brauer et ale (1975). The phenylthio-
hydantoin derivatives were identified on a Hewlett-Packard 1084 A liquid
chromatograph equipped with either a DuPont Zorbax ODS 4.6 rom column
or an Altex Ultrasphere C18 column and a 254 nm detector.
Amino acid analysis - Protein samples were prepared for amino acid
analysis by dialysis against 0.2 M acetic acid and lyophilization. For
determination of cysteine content, some samples were oxidized with
performic acid according to Moore (1963). The oxidation reaction was
quenched by the addition of HBr (Moore, 1963), and the samples were
dried on a vacuum centrifuge. Remaining traces of Br2 were removed by
adding a small amount of 88% formic acid and drying under vacuum once
again. Untreated and oxidized samples were hydrolyzed in 250 �l of 6 N
HCl at 1100C for 20 to 72 h in sealed tubes evacuated to below 25
millitorr. Hydrolysates were analyzed on a Durrum D-500 automatic amino
acid analyzer.
Preparation of gelatin- and lysine-Sepharose CL-4B - Sepharose CL-4B
was activated by cyanogen bromide in a high capacity buffer (Porath et al.,
1973). Swollen Sepharose CL-4B (500 ml) was washed with 2 liters of 1.0 M
potassium phosphate, pH 12.1, by filtering under vacuum on a coarse
sintered glass funnel. The moist cake was suspended to a volume of 800 ml
o
with 1.0 M potassium phosphate, pH 12.1, and cooled to 5 to 10 C by gently
 
28
stirring in an ice bath. Cyanogen bromide (100 g) was dissolved in
approximately 100 ml of N,N-dimethylformamide (Blackburn et al., 1977)
and added to the Sepharose with stirring over a period of 2 min. The
reaction mixture was then stirred for an additional 30 min. The
temperature was maintained at 5 to 100C by addition of ice. The
activated Sepharose was washed with approximately 4 liters of cold
distilled water and either used immediately for coupling or stored
o
in dry acetone at 4 C.
The Sepharose was prepared for coupling by washing it with 2 liters
of 0.1 M NaHC03, pH 8.9. (Deutsch and Mertz, 1970). Gelatin (5 g) was
dissolved in 500 ml of warm 0.1 M NaHC03, pH 8.9. The solution was
allowed to cool, mixed with the moist cake of Sepharose, and placed on
a rotary shaker at room temperature for several hours. The gelatin-
Sepharose was then washed with 2 liters of 2.0 M NaCI, 0.1 M NaHC03,
pH 8.9, to remove unbound ligand, and with 2 liters of 0.1 M NaHC03,
pH 8.9, to remove salt. Any unsubstituted groups which remained
were quenched by mixing the washed Sepharose with 250 ml of 0.1 M
ethano lamine-HCI , pH 9.0, on a rotary shaker for 2 h at room
temperature. The gelatin-Sepharose was then washed with 2 liters of
PBS and stored suspended in PBS containing 0.02% NaN3 at 4°C.
Lysine-Sepharose was prepared similarly, except that 100 g of lysine
were dissolved in 500 ml of 0.1 M NaHC03, pH 8.9, and the coupling
reaction was carried out overnight at 4°C (Deutsch and Mertz, 1970).
Reduction and alkylation - Proteins were exhaustively reduced
and alkylated essentially according to Konigsberg (1972). Samples
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were dialyzed against 0.5 Tris-HCI, 5 mM Na2EDTA, pH 8.5. Dialyzed
solutions were then made approximately 6 M in guanidine HCI and
heated for 3 to 5 min at 100oC. Samples were flushed with N2 and
incubated at 500C for 30 min. A 20- to 50-fold molar excess of
dithiothreitol (compared with moles of cysteine in the protein) was
added. The solution was again flushed with N2, and incubation at
500C was continued for an additional 4 h. The solution was cooled
to room temperature, a slight molar excess (compared with moles of
dithiothreitol) of iodoacetic acid was added, and the sample was
incubated in the dark for 5 min. Two more aliquots of iodoacetic
acid equal to the first were added, followed by incubations in the
dark of 5 min and 20 min, respectively. The solution was then
dialyzed in the dark at 40C against an appropriate buffer containing
0.1% 2-mercaptoethanol (v/v). Subsequent changes of dialysis buffer
contained no 2-mercaptoethanol.
Immunological techniques - For preparation of antiserum, 100 to
250 �g of purified plasma fibronectin were electrophoresed on a 5%
acrylamide gel in the presence of SDS and 2-mercaptoethanol. Following
electrophoresis, vertical strips were sliced from the gel, fixed and
stained, and used as guides to determine the position of the fibronectin
band. Fibronectin-containing regions of the gel were excised, ground
with a mortar and pestle, mixed with complete Freund's adjuvant, and
injected into an adult New Zealand white rabbit. Injections prepared
similarly, but with incomplete rather than complete adjuvant, were
repeated at weekly intervals for three weeks. Beginning three weeks
after the last injection, antiserum was collected and prepared by
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standard techniques and stored at -20oC. Double immunodiffusion was
performed by the method of Ouchter1ony (1958).
Preparation of human plasmin - Plasminogen was isolated from
human acid citrate dextrose plasma by 1ysine-Sepharose affinity
chromatography (Deutsch and Mertz, 1970) and activated by streptokinase
as described by Robbins and Summaria (1970).
Estimation of protein concentration - Protein concentrations were
determined by the method of Lowry et a1. (1951) using bovine serum
albumin as a standard, or by absorbance at 280 nm using an E1 /cm1 valuemg





Plasma fibronectin - Fibronectin was isolated from human plasma
by affinity chromatography on gelatin-Sepharose. A first attempt at
affinity purification, using the method of Engvall and Ruoslahti
(1977), yielded fibronectin which was obviously degraded; therefore,
this procedure was modified to minimize the possibility of proteolytic
digestion of the molecule during processing. Protease inhibitors were
present throughout the early steps of purification, and vitamin K­
dependent proteases of the clotting cascade were removed from the
plasma by adsorption to barium (Aronson and Menache, 1966). Furthermore,
since plasma fibronectin is susceptible to cleavage by plasmin (A.B. Chen
et al., 1977; Jilek and Hormann, 1977a; Iwanaga et al., 1978), plasminogen
was removed from the plasma by lysine-Sepharose affinity chromatography
(Deutsch and Mertz, 1970). Plasma fibronectin purified with these
precautions showed no evidence of proteolytic degradation as monitored
by SDS-polyacrylamide gel electrophoresis even after incubation at 370C
for 24 h (not shown). Carbamylation of amino groups in the protein was
avoided by using guanidine HCl rather than urea (Engvall and Ruoslahti,
1977).to elute fibronectin from the gelatin-Sepharose.
Fibronectin samples prepared by gelatin affinity chromatography were
seen to contain three prominent contaminants, with apparent molecular
weights of 69,000, 53,000 and 49,000, when examined by SDS-polyacrylamide
gel electrophoresis in the presence of 2-mercaptoethanol (Fig. lD). It
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Figure 1. PURIFICATION OF HUMAN PLASMA FIBRONECTIN
Details of the experimental procedure are given under "Methods".
Protein samples were applied to a 5 to 16% gradient polyacrylamide
gel containing SDS with (A to F) or without (G and H) prior
reduction. A, human plasma (70 �g); B, human plasma following
gelatin-Sepharose chromatography (70 �g); C, protein eluted from
gelatin-Sepharose with 1 M guanidine HCl (2 �g); D, same as C
(20 �g); E and G, protein eluted from gelatin-Sepharose and further
purified by DEAE-cellulose chromatography (2 �g); F and H, same as
E and G (20 �g). The scale indicates the positions of molecular
weight standards listed under "Methods".
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fibrinogen, which have molecular weights of approximately 71,000,
60,000, and 49,000 (Mosesson et al., 1972, 1973). Therefore, the
fibronectin preparation was chromatographed on DEAE-cellulose,
using a procedure specifically designed to separate fibronectin and
fibrinogen (Mosesson and Umfleet, 1970). As seen in Fig. IF, material
purified on DEAE-cellulose contained no trace of the suspected
fibrinogen contaminants.
Yields of 55 to 120 mg of purified fibronectin were obtained
routinely from 900 to 1200 ml of pooled plasma. It has been
determined, using immunochemical techniques, that normal adult human
plasma contains from 150 to 720 mg of fibronectin per liter (Mosher
and Williams, 1978). Since very little protein was lost during
DEAE-cellulose chromatography, it would seem that gelatin-Sepharose
affinity chromatography did not completely remove fibronectin from
plasma. However, plasma that had been passed over a gelatin-Sepharose
column contained no fibronectin detectable by SDS-polyacrylamide gel
electrophoresis or by double immunodiffusion using antiserum to human
plasma fibronectin (not shown). The reasons for this discrepancy
remain unclear.
SDS-polyacrylamide gel electrophoresis of isolated plasma
fibronectin under reducing conditions revealed two closely spaced
bands with apparent molecular weights of approximately 250,000 and
245,000 (Fig. IE). Other laboratories have also reported that the
subunits of plasma fibronectin migrate as a closely spaced doublet
of bands; however, their estimates of the subunit molecular weights
were lower, ranging from 200,000 to 220,000 (Mosesson et al., 1975;
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Iwanaga et al., 1978; Yamada and Kennedy, 1979). This discrepancy
is probably a reflection of the different gel systems used, and
emphasizes the inaccuracy inherent in the determination of molecular
weights of large molecules by SDS-polyacrylamide gel electrophoresis.
Smaller polypeptides were also seen in the fibronectin sample,
most notably with molecular weights of 150,000, 95,000, and 60,000.
Several faint bands representing proteins with molecular weights
ranging from 210,000 to 170,000 were detected as well. These components
may be just visible in Fig. IF. It is likely that some or all of these
contaminants represent fragments of plasma fibronectin generated in vivo.
A. B. Chen et ale (1977) have reported that similar proteins were
present in material precipitated from freshly prepared plasma by anti­
serum to plasma fibronectin. Furthermore, these same proteins were
seen in samples of fibronectin isolated by gelatin-Sepharose affinity
chromatography from plasma collected directly into a mixture of
protease inhibitors, including soybean trypsin inhibitor,
N-ethylmaleimide, pepstatin, benzamidine HCI, PhCH2S02F, and Na2EDTA
(not shown).
Analysis of nonreduced, purified plasma fibronectin by poly­
acrylamide gel electrophoresis showed the molecule to exist primarily
as a species with an apparent molecular weight of approximately
400,000, although some higher molecular weight aggregates and monomers
of 245,000 and 250,000 daltons were also present (Fig. 1, G and H).
The 400,000 dalton band undoubtedly represents dimers of 245,000
and 250,000 dalton subunits, since Mosesson et ale (1975) have
demonstrated that native plasma fibronectin occurs largely in this form.
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Cellular fibronectin - Cellular fibronectin was purified from the
conditioned media of human embryonic fibroblast cultures by gelatin­
Sepharose affinity chromatography according to Teng and Rifkin (1979).
As seen in Fig. 7A, the subunits of the cellular form of the molecule
did not migrate as a doublet, but as a broad, diffuse band. In the
polyacrylamide gel system employed, cellular fibronectin subunits
migrated slightly more slowly than the subunits of plasma fibronectin
(not shown). Samples of cellular fibronectin prepared in this manner
were not as pure as corresponding samples of the plasma form. However,
because of the relative insolubility of cellular fibronectin under
physiological conditions and the difficulty of obtaining large amounts
of material, no attempt was made to purify the molecule further.
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Peptide Mapping of Plasma Fibronectin Subunits
The relationship between the 245,000 dalton and 250,000 dalton
subunits of plasma fibronectin was examined using a one-dimensional
peptide mapping technique developed by Cleveland et ale (1977).
125Subunit bands, labeled with I (McConahey and Dixon, 1966), were
sliced from an SDS-polyacrylamide gel and placed in the sample wells
of a second polyacrylamide gel. Staphylococcus aureus V8 protease,
which is active in SDS, was then added to each well to generate an
array of fragments. In Fig. 2, Band C, gel slices containing either
of the subunits were electrophoresed in the absence of protease to
demonstrate that these two polypeptides could be separated cleanly
from one another. The peptide maps derived from the two subunits were
identical (compare Fig. 2E with Fig. 2F, and Fig. 2H with Fig. 2I).
As a control, the three subunit chains of bovine fibrinogen, which are
known to be dissimilar, were analyzed in a similar manner. As expected,
the peptide maps of these chains were clearly different from one
another (not shown).
These experiments indicate that the 245,000 dalton and 250,000
dalton subunits of plasma fibronectin are very similar. The difference
in molecular weights of the chains must arise from only a slight
difference in the primary structure of the two polypeptides.
Alternatively, the two subunits may have identical polypeptide backbones,
but migrate differently because they are glycosylated to different extents.
This hypothesis is supported by results of Wagner and Hynes (1979), who
metabolically labeled cellular fibronectin with (3H)glucosamine and
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Figure 2. PEPTIDE MAPPING OF PLASMA FIBRONECTIN SUBUNITS
Details of the experimental procedure are given under "Methods".
Gel slices containing one or both bands of the reduced fibronectin
doublet were placed in the sample wells of a 5% (A to C) or an 8
to 18% gradient (D to I) polyacrylamide gel containing SDS. The
slices were then overlaid with the indicated amounts of S. aureus
V8 protease, and electrophoresis was carried out as indicated in
the text. A to C, no protease: A, 245 and 250 kd bands; B, 250
kd band; C, 245 kd band. D to F, 0.05 �g of protease: D, 245 and
250 kd bands; E, 250 kd band; F, 245 kd band. G to I, 0.5 �g of
protease: G, 245 and 250 kd bands; H, 250 kd band; I, 245 kd band.
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(l4C)amino acids. This material migrated as a broad band on SDS-
polyacrylamide gels.
3 14
The ratio of H to C was higher in slices
cut from the upper part of the band than in slices cut from the lower
portion; this finding indicates that the more slowly migrating
fractions of fibronectin contained a proportionately greater amount
of glucosamine than the more rapidly migrating fractions did. In any
event, the close similarity of the subunits to one another simplified
the design and interpretation of the proteolytic digestion experiments
that follow, since cleavage of either chain could be expected to
yield similar fragments.
It is not known whether plasma fibronectin molecules are hetero-
dimers or homodimers. That is, a single dimeric fibronectin molecule
may be composed of one 245,000 dalton subunit and one 250,000 dalton
subunit, or there may be two different classes of fibronectin dimers,
each composed of identical subunits. However, observations that dimeric
plasma fibronectin appeared as a single band in gels (Fig. 1, G and H)
and that the two monomer bands always stained with approximately equal
intensity tend to support the former possibility.
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Analysis of Fibronectin Structure with Thrombin
The first protease used for the analytical dissection of
fibronectin was thrombin. Thrombin was chosen for two reasons:
first, it is quite specific in its action and might be expected to
introduce only a limited number of cleavages in the fibronectin
chain; second, fibronectin is a potential substrate for thrombin
in vivo, although there is no evidence to date which indicates that
such an interaction occurs.
Cleavage of fibronectin with thrombin - Incubation of plasma
fibronectin with human a-thrombin generated three major fragments:
two large ones with molecular weights, as determined by SDS-polyacrylamide
gel electrophoresis under nonreducing conditions, of approximately 235,000
and 230,000, and a small one with a molecular weight of 26,000 (Fig. 3,
E to H). Reduction of the digest with 2-mercaptoethanol prior to
electrophoresis caused no change in the apparent molecular weights of
the large fragments, but that of the small fragment rose to 29,000
(Fig. 3, A to D). This unexpected rise in molecular weight suggests
that the small fragment contains a large number of intrachain disulfide
bonds. The presence of such bonds may prevent the nonreduced molecule
from assuming the extended, rod-like configuration typical of SDS-protein
complexes (Reynolds and Tanford, 1970), thus resulting in aberrant
migration. Similar atypical electrophoretic behavior has been described
for fibronectin fragments produced by trypsin (Wagner and Hynes, 1979)
and cathepsin D (Balian et al., 1979) digestion. Other proteases also
yield patterns of digestion similar to that obtained with thrombin; both
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Figure 3. DIGESTION OF PLASMA FIBRONECTIN vlITH THROMBIN
Plasma fibronectin (1 mg/ml of PBS) was mixed with human
a-thrombin (50:1, w/w) and incubated at 37oC. Protein samples
were applied to a 5 to 16% gradient polyacrylamide gel containing
SDS with (A to D) or without (E to H) prior reduction. A and E,
plasma fibronectin alone; Band F, mixture incubated 15 min; C
and G, mixture incubated 1 h; D and H, mixture incubated 2 h.
Each lane contains 6 �g of protein. Arrows indicate the
a-thrombin bands. The scale indicates the positions of
molecular weight standards listed under "Hethods".
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plasmin cleavage of plasma fibronectin (A.B. Chen et al., 1977; Jilek
and H5rmann, 1977a; Iwanaga et al., 1978) and trypsin cleavage of
cellular fibronectin (Wagner and Hynes, 1979) produce large fragments
of approximately 200,000 daltons and small fragments of 23,000 to
29,000 daltons. These results indicate that fibronectin may contain
a region that is highly susceptible to cleavage by serine proteases.
Since none of the thrombin-derived fragments showed a decrease in
apparent molecular weight upon reduction, it is likely that all three
are composed of single polypeptide chains. It is possible that the
nonreduced small fragment is actually composed of two 29,000 dalton
subunits and migrated anomalously as a 26,000 dalton species due to
extensive disulfide bonding. However, results of the experiment
depicted in Figure 4 suggest that the interchain disulfide bond(s)
of fibronectin are located not within the small fragment, but within
another peptide situated close to one end of the molecule. At early
times of digestion by thrombin, plasma fibronectin fragments with
molecular weights nearly identical with those of intact monomers were
liberated (compare Fig. 4, B to D, with Fig. 4J). This observation
suggests that removal of a small fragment, probably weighing no more
than several thousand daltons, from one end of the molecule results in
the concomitant removal of all linkages which join the subunits of this
dimer. The monomer-length fragments appeared only transiently; fragments
of 230,000 and 235,000 daltons accumulated at later times (Fig. 4, G to
I). Minor components which migrated just ahead of and behind the large
fragments were also observed after prolonged digestion. Whereas the
former species is probably derived from further cleavage of the large













Figure 4. TIME-COURSE OF DIGESTION OF PLAS�� FIBRONECTIN
WITH THROMBIN
Plasma fihronectin (1 mg/m1 of PBS) was mixed with human a-thrombin
(50:1, w/w) and incubated at 37°C. Protein samples were applied to
a 5 to 16% gradient polyacrylamide gel containing SDS with (J) or
without (A to I) prior reduction. Fixed, stained gels were then
scanned with a densitometer. A and J, plasma fibronectin alone;
B to I, mixture incubated for the following times: B, 10 min; C,
20 min; D, 40 min; E, 60 min; F, 90 min; G, 2 h; H, 4 h; I, 6 h.
Each lane contains 8 ug of fibronectin. The arrows indicate the
positions of migration of the fibronectin dimer and monomer,
a-thrombin, and a 29 kd fibronectin fragment.
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It thus appears that thrombin cleaves fibronectin a't a minimum of two
sites. One cleavage removes a small fragment, which contains all of the
interchain disulfide linkages, from one end of the molecule. A second
cleavage produces the 235,000, 230,000, and 29,000 dalton fragments. It
should be emphasized, however, that fragments containing the interchain
bonds were not detected in the thrombin digests. Furthermore, the
presence of aggregated material at the top of the gel, as well as the
lack of a clear separation between some of the peaks, makes a detailed,
quantitative analysis of the scans shown in Figure 4 difficult. Further
research will be required to locate the position of the interchain bonds
with certainty.
As mentioned, the pattern of thrombin digestion seen in these
experiments is quite similar to that reported for plasmin degradation
of plasma fibronectin (A.B. Chen et al., 1977; Jilek and Hormann, 1977a;
Iwanaga et al., 1978). Furthermore, fibronectin has previously been
reported to be resistant to thrombin attack (Mosesson and Umfleet,
1970; Zetter et al., 1976). To ensure that the observed degradation
was indeed due to thrombin and not to small amounts of contaminating
plasmin, thrombin digestions were performed in the presence of the
protease inhibitors Trasylol and hirudin. Trasylol is an efficient
inhibitor of plasmin (Feeney et al., 1969) but not of thrombin, whereas
hirudin specifically blocks thrombin (Markwardt, 1970). As seen in
Figure 5, hirudin completely inhibited digestion of plasma fibronectin
by the thrombin preparation (Fig. 5D); in contrast, Trasylol had no
effect (Fig. 5C). As expected, the converse result was obtained when
digestion of fibronectin by purified human plasmin was examined.
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Figure 5. EFFECT OF PROTEASE INHIBITORS ON DIGESTION OF PLAS}�
FIBRONECTIN WITH THROMBIN AND PLASMIN
Thrombin and plasmin were incubated for 0.5 h at room temperature
with or without the addition of Trasylol or hirudin (10 U of
inhibitor/�g of protease). Plasma fibronectin was then mixed with
the thrombin (35:1, w/w) or plasmin (75:1, w/w) preparations and
incubated at 370C for an additional 2 h. Reduced samples were
applied to a 5 to 16% gradient polyacrylamide gel containing SDS.
A and J, plasma fibronectin alone; B, fibronectin plus thrombin;
C, fibronectin plus thrombin and Trasylol; D, fibronectin plus
thrombin and hirudin; E, fibronectin plus thrombin, Trasylol, and
hirudin; F, fibronectin plus plasmin; G, fibronectin plus plasmin
and Trasylol; H, fibronectin plus plasmin and hirudin; I, fibro­
nectin plus plasmin, Trasylol, and hirudin. Each lane contains
6 �g of fibronectin. The scale indicates the position of molecular
weight standards listed under "Methods".
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of hirudin had no effect (Fig. 5H). Cleavage of fibronectin by the
human thrombin preparation thus appears to result from the action of
thrombin alone and not from that of any contaminating proteases.
The results of this experiment also demonstrate that plasmin
and thrombin do not cleave plasma fibronectin identically. Although
both proteases produced small fragments of 29,000 daltons, plasmin
yielded relatively greater amounts of the 230,000 dalton fragment and
lesser amounts of the 235,000 dalton fragment than did thrombin
(compare Fig. 5B with Fig. 5F). An additional fragment of approximately
200,000 daltons was seen in the plasmin digests (Fig. 5F), but also
appeared after prolonged digestion of fibronectin with thrombin (Fig. 41).
When a thrombin digest of plasma fibronectin was passed over a
column of gelatin-Sepharose, it was discovered that the small, 29,000
dalton fragment was not retained. The large fragments, however, were
still capable of binding to gelatin and could be eluted from the
column with 2.0 M guanidine HCI. Thus, the digest could be separated
into two fractions for further analysis: one containing the large,
230,000 and 235,000 dalton pieces as well as remaining undigested
fibronectin (Fig. 6D), and one containing primarily the small, 29,000
dalton fragment (Fig. 6E). The small fragment preparation contained
traces of higher molecular weight polypeptides, the major contaminant
having a molecular weight of about 30,000. However, densitometric
scans of Fig. 6E indicated that the 29,000 dalton fragment was more
than 95% pure (not shown).
Thrombin cleavage of fibronectin isolated from the culture medium
of human embryonic fibroblasts produced fragments similar to those
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Figure 6. SEPARATION OF THROMBIN-DERIVED PLASMA FIBRONECTIN FRAGMENTS
Human plasma fibronectin (3.3 to 5 mg/ml of PBS) was mixed with human
a-thrombin (133:1, w/w) and incubated at 370C for 1 h. Fragments were
then separated by gelatin-Sepharose affinity chromatography as discussed
under "Methods". Reduced protein samples were applied to a 5 to 16%
gradient polyacrylamide gel containing SDS. A, plasma fibronectin
plus thrombin prior to incubation (2.5 �g); B, fibronectin plus thrombin
after incubation (2.5 �g); C, fibronectin plus thrombin incubated and
passed over phosphocellulose (2.5 �g); D, fraction of thrombin digest
bound to gelatin-Sepharose (3.3 �g); E, fraction of thrombin digest
not retained by gelatin-Sepharose (7 �g). The amount of thrombin in
the digestion mixture is too small to be seen on this gel. The scale




of the cellular fibronectin digests in the presence of 2-mercaptoethanol
revealed two major components: a diffuse band or group of bands
migrating just ahead of intact cellular fibronectin, and a band
migrating with an apparent molecular weight of 29,000 (Fig. 7, B and C).
Less prominent bands with molecular weights of 28,000 and 30,000 were
also detected. Like the 230,000 and 235,000 dalton plasma fibronectin
fragments, the large cellular fibronectin fragments retained the
ability to bind to gelatin-Sepharose (Fig. 71); the small, 29,000
dalton fragment did not bind (Fig. 7, D to H). Although it may not be
evident from Figure 7, samples of intact cellular fibronectin and its
thrombin-derived fragments were considerably less pure than corresponding
samples of plasma fibronectin and its fragments.
NHz-terminal analysis of intact fibronectin and thrombin-derived
fragments - When intact plasma fibronectin or the thrombin-generated
small fragment was analyzed by the dansyl chloride technique, no
NH2-terminal amino acids were detected •. Exhaustive reduction and
alkylation of the samples prior to analysis did not affect these
results, indicating that failure to see an NH2-terminal residue was
probably not due to its inaccessibility to the dansy1 reagent.
Treatment of the pooled large fragments, on the other hand, yielded
a single dansyl-amino acid which co-chromatographed with standard
dansy1-a1anine.
Since plasma fibronectin has been reported to contain NH2-termina1
pyrog1utamic acid (Mosesson et a1., 1975), an attempt was made to
remove the blocking residue with L-pyrog1utamy1-peptide hydrolase and
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Figure 7. DIGESTION OF CELLULAR FIBRONECTIN WITH THROHBIN AND
SEPARATION OF FRAGMENTS
Human cellular fibronectin (2.9 mg/ml of PBS) was mixed with human
a-thrombin (100:1, w/w) and incubated at 370C for 1.5 h. Fragments
were then separated by gelatin-Sepharose affinity chromatography as
discussed under "Methods". A, cellular fibronectin plus thrombin
prior to incubation (7 �g); B, fibronectin plus thrombin after
incubation (7 �g); C, fibronectin plus thrombin incubated and passed
over phosphocellulose (12 �g); D to H, fractions containing digest
components not bound by gelatin-Sepharose (1.5 �g, 4.6 �g, 5.3 �g,
1.7 �g, and 0.8 �g, respectively); I, digest components bound to
gelatin-Sepharose (5 �g); J, 29 kd fragment produced by thrombin
digestion of human pLasma fibronectin (8 ug ) ; K, molecular weight
standards. The scale indicates the molecular weights of the




















thus expose the next amino acid in the sequence. The enzyme had a
specific activity of 50 units/mg using L-pyroglutamyl-L-alanine as a
1
substrate. After treatment with the L-pyroglutamyl-peptide hydrolase,
both the intact molecule and the small fragment had an NH2-terminal
alanine residue, as monitored by dansylation. As a control, proteins
and enzyme were incubated separately and mixed together only
immediately prior to boiling with SDS. No NH2-terminal amino acids
were detected in these preparations. Neither whole plasma
fibronectin nor the small fragment appeared degraded after enzyme
treatment when examined by SDS-polyacrylamide gel electrophoresis
(compare Fig. 8A with Fig. 8B, and Fig. 8F with Fig. 8G), although
small changes in molecular weight would not be detectable by this
technique.
A similar analysis was performed on intact cellular fibronectin
and its thrombin-derived fragments. However, the results of these
experiments were less clear-cut because of the relative impurity of
the cellular fibronectin preparations. Chromatography of hydrolysates
of dansylated, intact cellular fibronectin revealed three faint spots.
Two of these were identified as dansyl-alanine and dansyl-glycine.
The third spot did not co-migrate with any of twenty dansyl-amino acid
standards. This spot might represent a hydrolysis-resistant dansyl-
dipeptide; however, the reported chromatographic behaviors of such
dipeptides are not consistent with the behavior of the unidentified
derivative (Sutton and· Bradshaw, 1978). Identical results were
1
A unit is defined as the amount of enzyme which will release 1.0 nmol
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Figure 8. EFFECT OF L-PYROGLUTAMYL-PEPTIDE HYDROLASE TREATMENT ON
ELECTROPHORETIC MOBILITY OF INTACT PLASMA FIBRONECTIN
AND SOME OF ITS FRAGMENTS
Intact fibronectin, a 29 kd fragment produced by thrombin digestion,
and a 72 kd gelatin-binding fragment produced by cathepsin D digestion
were isolated and digested with L-pyroglutamyl-peptide hydrolase as
discussed under "Methods". Nonreduced samples were applied to a 5 to
16% gradient polyacrylamide gel containing SDS. A and B, reduced and
alkylated intact fibronectin before (A) and after (B) L-pyroglutamyl­
peptide hydrolase digestion (5.5 �g); C and D, 72 kd fragment before
(C) and after (D) digestion (1 �g); E, 29 kd fragment (10 �g); F and
G, reduced and alkylated 29 kd fragment before (F) and after (G)
digestion (7 �g). The scale indicates the positions of molecular
weight standards listed under "Methods".
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obtained from dansyl analysis of the 29,000 dalton cellular
fibronectin fragment. Treatment of the intact molecule with
L-pyroglutamyl-peptide hydrolase led to a marked increase in
fluorescence at the dansyl-alanine position; the other two spots
remained faint. Analysis of the large cellular fibronectin
fragments yielded a single spot, which was identified as dansyl­
alanine.
Although these results are not conclusive, it appears that
human cellular fibronectin, like the plasma form, contains an NH2-
terminal pyroglutamic acid residue and alanine as the penultimate
residue. Furthermore, cleavage of cellular fibronectin with
thrombin produced a small fragment with a blocked NH2-terminus and
large fragments with NH2-terminal alanine. It has been reported that
chicken cellular fibronectin also has a blocked NH2-terminus; however,
the blocking residue was not removed by treatment with L-pyroglutamyl­
peptide hydrolase (Yamada et al., 1977a). Therefore, the NH2-terminus
of fibronectin from this species may consist of a residue with an
acylated a-amino group, rather than pyroglutamic acid.
Automated sequence analysis of intact plasma fibronectin and
thrombin-derived fragments - Analysis of whole plasma fibronectin and
its thrombin-derived fragments by an automated amino acid sequencer
confirmed the results of the dansylation study. Intact plasma fibronectin
and the small fragment yielded no phenylthiohydantoin derivatives,
indicating NH2-terminal blockage. The pooled large fragments gave the
sequence Ala-Ala-Val-Tyr-. After treatment with L-pyroglutamyl-peptide
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hydrolase, both the intact molecule and the small fragment yielded the
sequence Ala-Glx-Glx-Met-Val-.
The yield of alanine at the first step of sequencing, expressed
as a percentage of the number of nanomoles of protein applied to the
sequencer, was approximately 52% for the large fragments, 42% for the
intact molecule, and 52% for the small fragment. It should be noted
that the large fragment sample contained a considerable proportion of
undigested, blocked molecules; it has been estimated from densitometric
scans of SDS-polyacrylamide gels that the fragments constituted only
60 to 75% of the protein applied (not shown). The corrected yield of
alanine, then, was approximately 70 to 87%. There are several steps
in the automated sequencing process where protein can be lost, including
transfer of the protein to the sample cup, drying of the protein onto
the cup as a film, and initial washing of the protein film. In fact,
it has been reported that a yield of only 50 to 70% can be expected at
the first step of automated sequencing under usual conditions (Niall,
1973). Although the yields obtained from the intact molecule and the
small fragment clearly lie near the lower end of this range, it may
be that the conditions employed did not permit complete enzymatic
removal of NH2-terminal pyroglutamic acid. In any case, it is evident
that in all three instances, the observed sequences were derived from
the major portion of the protein samples applied and did not arise
from minor contaminants. Because of the difficulty in obtaining
sufficient quantities of highly purified material, automated sequence
analysis of cellular f Lbronec tLn was not performed.
 
53
Summary - Human plasma fibronectin was cleaved by thrombin, and
three major fragments were recovered: two large ones with molecular
weights of 230,000 and 235,000, and a small one with a molecular
weight of 29,000. No NH2-terminal residue was detected, using the
dansyl chloride method, in either the intact molecule or the small
fragment. Analysis of the large fragments revealed NH2-terminal
alanine. Treatment of both the intact molecule and the small
fragment with L-pyroglutamyl-peptide hydrolase resulted in the
appearance of NH2-terminal alanine. Automated sequence analysis
confirmed these findings and demonstrated that the intact molecule
and the small fragment have identical NH2-terminal sequences. From
these results, it is concluded that the small 29,000 dalton fragment
is located at the NH2-terminus of the parental molecule, whereas the
large fragments constitute the carboxyl portion, as shown in Figure 9.
Preliminary analysis of human cellular fibronectin indicates that it
contains a homologous thrombin-sensitive site.
The location of the interchain disulfide linkage(s) cannot be
determined with certainty from these data. However, as previously
discussed, results of the preliminary experiment shown in Figure 4
suggest that these bonds may be located no more than several thousand
daltons from one end of the molecule. Wagner and Hynes (1979) have
similarly concluded, from results of digestion of cellular fibronectin
with trypsin, that the interchain disulfide bonds are located less than
10,000 daltons from one end. Since it has been established that the
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Figure 9. LOCATION OF THROMBIN-DERIVED FRAGMENTS WITHIN INTACT
FIBRONECTIN
The small fragment is located at the NH2-terminus; the large fragments
constitute the carboxyl portion. Dashed lines denote proposed sites
of thrombin cleavage. Apparent molecular weights of the intact
polypeptide chains and thrombin-derived fragments, as determined by
SDS-polyacrylamide gel electrophoresis under reducing conditions, are
indicated by numbers between horizontal arrows. As discussed in the




fibronectin, it is therefore likely that the interchain bonds are
located near the COOH-terminus (Figure 9). Experiments designed to
test this hypothesis are in progress.
Wagner and Hynes (1980) have obtained other evidence which also
suggests that the interchain disulfide bonds are located near the
carboxyl, rather than the amino, end of fibronectin. Hamster cellular
fibronectin was treated with DTNB, which reacts with cysteine residues.
The fibronectin was then incubated with Na14CN, which cleaves
peptide bonds rapidly at modified cysteine groups and, more slowly,
at cystine residues. The first fragments to appear in the cyanide
digests had apparent molecular weights of 170,000 and 33,000, as
determined by SDS-polyacrylamide gel electrophoresis under reducing
conditions. The nonreduced 33,000 dalton fr�gment was involved in
a disulfide-bonded complex, the components of which were not charac­
terized. In contrast, the 170,000 dalton fragment contained no
interchain disulfide bonds. Only the 33,000 dalton fragment was
labeled with 14C• Since the (14C)cyanide is incorporated into peptides
formed to the carboxyl side of the cleaved bond, it follows that the
170,000 dalton fragment represents the amino end of fibronectin. The
interchain disulfide bonds, therefore, must be situated near the
COOH-terminus.
Iwanaga et ale (1978) have described experiments in which they
digested bovine plasma fibronectin with plasmin and separated the
resulting fragments by gel filtration. They, too, obtained a small
fragment of 29,000 daltons and a large one of about 200,000 daltons.
However, in this case, NH2-terminal analysis of the fragments led to
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the conclusion that the large fragment is located at the amino end of
fibronectin and the small one at the COOH-terminus. The first two
NH2-terminal residues which Iwanaga et ale (1978) found in the intact
bovine molecule, <Glu-Ala-, are the same as reported here and by
Mosesson et ale (1975) for human fibronectin. The third residue,
threonine, is different, but this variation may represent heterogeneity
between the two species. The NH2-terminal sequence that they reported
for the 29,000 dalton fragment, Val-Val-Gln-, shares no obvious
similarities with the sequence obtained from the thrombin-derived small
fragment. Furthermore, careful examination of the automated sequence
data for the thrombin-derived small fragment gave no indication that
a protein with this sequence was present as a minor component of the
preparation.
The explanation for the differences in results of these two sets
of experiments is unclear. It is unlikely that the bovine and human
proteins differ greatly in structure, since fibronectin has been
highly conserved during evolution (Kuusela et al., 1976). It is
evident from Figure 5 that plasmin and thrombin cleave fibronectin in
a similar, but not identical, manner. Since Iwanaga et ale (1978) did
not report any quantitative data, it is conceivable that the NH2-
terminal sequence which they detected in the 29,000 dalton fragment
sample was derived from a minor component that is present in plasmin,
but not thrombin, digests. It is more difficult to explain why their
large fragment preparation was found to contain the same NH2-terminal
sequence as the intact molecule.
Although the data reported by Iwanaga et ale (1978) contradict the
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conclusions presented in this thesis, results of experiments by others
are in complete agreement. Wagner and Hynes (1980) have mapped tryptic
fragments of cellular fibronectin, using a procedure modified from
(35) h" "Dintzis (1961). Hamster fibroblasts were incubated with S met 10nlne
and lysed; newly synthesized, labeled fibronectin was isolated from the
lysates by gelatin-Sepharose affinity chromatography. The periods
of labeling were shorter than the time required to synthesize a
complete fibronectin molecule. Therefore, since protein synthesis
proceeds from the NH2-terminus toward the carboxyl end, newly
synthesized molecules contained the greatest density of label in their
carboxyl portions. Cleavage of the pulse-labeled molecules with
trypsin produced fragments of 25,000 daltons and 200,000 daltons.
The 200,000 dalton fragment was labeled preferentially during very
short incubations with (35S)methionine; as the length of the labeling
period increased, the numbers of counts in the two fragments reached
a constant ratio. These results indicate that the 25,000 dalton
trypsin-generated fragment is located at the NH2-terminus of cellular
fibronectin. It is likely that this fragment is equivalent to the
29,000 dalton, thrombin-derived plasma fibronectin fragment. Both
lack the ability to bind to gelatin, show similar anomalous migration
in SDS-polyacrylamide gels, and as will be discussed, contain a high
proportion of cysteine (Wagner and Hynes, 1979). Thus, the findings
of Wagner and Hynes independently corroborate the model of fibronectin
presented in Figure 9.
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Location of a Gelatin-binding Region of Plasma Fibronectin
Both plasma and cellular fibronectins specifically interact with
collagen in a variety of in vitro assays (reviewed in Vaheri and
Mosher, 1978; Yamada and Olden, 1978; Mosher, 1980). Recently,
several laboratories have isolated proteolytically-derived fragments
of fibronectin that retain gelatin- or collagen-binding activity
(Balian et al., 1979; Gold et al., 1979; Hahn and Yamada, 1979a, 1979b;
Ruoslahti and Hayman, 1979; Ruoslahti et al., 1979). For example,
Balian et al. (1979) have used cathepsin D to produce a gelatin-binding
fragment of plasma fibronectin with a molecular weight of 72,000. This
fragment could be cleaved further with plasmin to yield a 42,000 dalton
fragment which retained the ability to bind to gelatin and a 30,000
dalton fragment which did not. Since it has been demonstrated that
plasmin and thrombin treatment of fibronectin result in similar patterns
of digestion (Fig. 5, B and F), it was reasoned that the 30,000 dalton
fragment described by Balian et al. might be similar or identical to the
29,000 dalton fragment generated by thrombin digestion of intact
fibronectin. This hypothesis predicts that the 72,000 dalton gelatin­
binding fragment produced by cathepsin D digestion is located at the
NH2-terminus of fibronectin. Thrombin treatment of this fragment should
produce a 29,000 dalton, NH2-terminal fragment which cannot bind to
gelatin and a 43,000 dalton fragment which retains gelatin-binding
activity. The experiments described below confirm these suppositions
and demonstrate conclusively that a gelatin-binding site of plasma
fibronectin is located within a 43,000 dalton region, adjacent to the
29,000 dalton, NH2-terminal peptide.
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Production and isolation of gelatin-binding fragments - Treatment
of human plasma fibronectin with cathepsin D as described by Balian
et ale (1979) resulted in a complex mixture of fragments (Fig. lOB).--
The two major components had molecular weights of approximately
150,000 and 72,000, as determined by SDS-polyacrylamide gel electro-
phoresis in the presence of a reducing agent. When the digest was
passed over a gelatin-Sepharose column, only three fragments were
retained: the 72,000 dalton fragment, and two minor components with
molecular weights of approximately 200,000 and 180,000 (not shown).
Since these higher molecular weight components were more prominent
at early times of digestion and disappeared as the 72,000 dalton
fragment accumulated (not shown), it is likely that they represent
precursors to the 72,000 dalton piece.
In order to purify the 72,000 dalton fragment, the digest was
first depleted of the higher molecular weight gelatin-binding
fragments by gel filtration on a column of Sephadex G-150. Two
overlapping peaks of protein were eluted from the column (Fig. 11);
material from the more slowly eluting peak (Fig. 10C) was subjected
to gelatin-Sepharose affinity chromatography. Most of the fragments
passed through the gelatin-Sepharose column (Fig. 10D); the material
that was bound and subsequently eluted with 2.0 M guanidine HCI
consisted of nearly pure 72,000 dalton fragment (Fig. 10E). Several
minor contaminants remained, including fragments of 200,000 and
180,000 daltons, as well as several pieces with molecular weights
ranging from approximately 55,000 to 68,000.
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Figure 10. PRODUCTION AND ISOLATION OF GELATIN-BINDING FRAGMENTS
OF PLAS}� FIBRONECTIN
Samples prepared as described under "Methods" were reduced and applied
to a 5 to 16% gradient polyacrylamide gel containing SDS. Sample A,
intact fibronectin (7 �g); Sample B, fibronectin digested with cathepsin
D (11 �g); Sample C, Sample B following Sephadex G-150 chromatography
to remove higher molecular weight components (13 �g); Sample D, fraction
of Sample C which did not bind to gelatin (3 �g); Sample E, gelatin­
binding fraction of Sample C (8 �g); Sample F, Sample E digested with
thrombin (10 �g); Sample G, Sample F following phosphocellulose
chromatography to remove thrombin (8 �g); Sample H, gelatin-binding
fraction of Sample G (5 �g); Sample I, fraction of Sample G which did
not bind to gelatin (5 �g); Sample J, 29 kd fragment isolated from
thrombin digests of intact fibronectin (5 �g); Sample K, mixture of
Samples I and J (10 �g). The scale indicates the positions of molecular
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Figure 11. GEL FILTRATION OF PLASMA FIBRONECTIN-CATHEPSIN D
DIGEST
Human plasma fibronectin was digested with cathepsin D, added to
a column of Sephadex G-150, and eluted. Details of the experi­
mental procedure are given under "Methods". Protein content of
the effluent was monitored by its absorption at 280 nm. A 72 kd
gelatin-binding fragment was obtained free of higher molecular
weight gelatin-binding components by pooling fractions 61 to 67
(indicated by the horizontal bar).
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As predicted, treatment of the purified 72,000 dalton fragment
with thrombin produced two major fragments which migrated, when
reduced, with apparent molecular weights of approximately 43,000
and 29,000 (Fig. 10, F and G). Passage of the digest over a
gelatin-Sepharose column demonstrated that the 43,000 dalton
fragment retained the ability to bind to gelatin (Fig. lOR), whereas
the 29,000 dalton fragment did not (Fig. 101). The 29,000 dalton
fragment prepared in this manner had an electrophoretic mobility
identical with that of the 29,000 dalton fragment prepared by
thrombin digestion of intact fibronectin (compare Fig. 101 with
Fig. 10J; see also Fig. 10K).
Preparations of both the 43,000 dalton and 29,000 dalton
fragments contained some impurities. The principal contaminant
in samples of the 43,000 dalton fragment consisted of a small amount
of undigested 72,000 dalton fragment (Fig. lOR). The 29,000 dalton
fragment preparation contained rather large amounts of impurities
migrating with molecular weights of 28,000 and 30,000 (Fig. 101).
The 29,000 dalton fragment sample prepared by thrombin digestion of
intact fibronectin contained only traces of such contaminants (Fig. 10J).
Results of SDS-polyacrylamide gel electrophoresis in the absence
of reducing agent suggest that the 72,000 dalton, 43,000 dalton, and
29,000 dalton fragments all consist of single polypeptide chains. The
nonreduced 72,000 dalton and 29,000 dalton fragments migrated more
rapidly than in the presence of a reducing agent (compare Fig. l2B
with Fig. l2F, and Fig. l2D with Fig. l2R), indicating that they
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Figure 12. ELECTROPHORETIC MOBILITY OF SOME CATHEPSIN D- AND
THROMBIN-DERIVED PLASMA FIBRONECTIN FRAGMENTS UNDER
REDUCING AND NONREDUCING CONDITIONS
Human plasma fibronectin was digested with cathepsin D, and a 72 kd
gelatin-binding fragment was isolated. The 72 kd fragment was
cleaved further with thrombin, and 29 kd and 43 kd fragments were
isolated. Details of the experimental procedure are given under
"Methods". Samples were applied to a 5 to 16% gradient polyacrylamide
gel containing SDS under reducing (A to D) or nonreducing (E to I)
conditions. A and E, plasma fibronectin digested with cathepsin D
(11 �g); Band F, 72 kd fragment (8 �g); C and G, 43 kd fragment
(5 �g); D and H, 29 kd fragment (5 �g); I, 29 kd fragment isolated
from thrombin digests of intact fibronectin (5 �g). The scale




contain intrachain, but not interchain, disulfide bonds. The
43,000 dalton fragment had similar mobilities under both reducing
and nonreducing conditions (compare Fig. 12C with Fig. 12G).
NH2-terminal analysis of the fragments - The 72,000 dalton
gelatin-binding fragment and its 43,000 dalton and 29,000 dalton
thrombin-generated derivatives were each subjected to NH2-terminal
analysis, using the dansyl chloride technique. No NH2-terminal
amino acids were detected in either the 72,000 dalton or 29,000
dalton fragments, indicating NH2-terminal blockage. Analysis of
the 43,000 dalton fragment, by contrast, revealed an NH2-terminal
alanine residue. Treatment of both the 72,000 dalton and 29,000
dalton fragments with L-pyroglutamyl-peptide hydrolase resulted
in the appearance of NH2-terminal alanine. Neither the 29,000 dalton
(not shown) nor the 72,000 dalton (Fig. 8, C and D) fragment appeared
degraded following enzyme digestion, as monitored by SDS-polyacrylaroide
gel electrophoresis.
Since all of the fragment preparations contained some impurities,
a quantitative confirmation of these results was obtained as follows.
The 72,000 dalton fragment was reduced and alkylated, digested with
L-pyroglutamyl-peptide hydrolase, and analyzed on an automated
sequencer. The NH2-terminal sequence obtained� Ala-Glx-Glx-Met-Val-,
is identical with that of L-pyroglutamyl-peptide hydrolase-treated
intact fibronectin. The yield of alanine at the first step of
sequencing was 59%, indicating. that the observed sequence· was not
derived from a minor contaminant.
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Summary - Treatment of human plasma fibronectin with cathepsin D
produced a gelatin-binding fragment with a molecular weight of 72,000.
This fragment could be cleaved further with thrombin to yield a 43,000
dalton fragment which bound to gelatin and a 29,000 dalton fragment
which did not. Results of NH2-terminal analysis of intact fibronectin
and the various proteolytically-derived fragments are summarized in
Table 1. Both the 72,000 dalton fragment and the 29,000 dalton
fragment derived from it by thrombin digestion have the same NH2-terminal
sequence, <Glu-Ala-, as intact fibronectin. In oontrast, the 43,000
dalton gelatin-binding fragment has an NH2-terminal alanine residue.
Automated amino acid sequence analysis of the 72,000 dalton piece
confirmed that this fragment contains the same NH2-terminal sequence as
intact fibronectin.
The model of human plasma fibronectin that can be constructed from
these data is shown in Figure 13. The 72,000 dalton gelatin-binding
fragment produced by cathepsin D digestion is located at the NH2-terminus
of the parental molecule. Further cleavage with thrombin yields a
29,000 dalton fragment which is also located at the NH2-terminus, and a
43,000 dalton fragment which constitutes the carboxyl portion of the
72,000 dalton piece. Since the 43,000 dalton fragment retains the
ability to bind to gelatin, one or more gelatin-binding sites of
fibronectin must be located within this region.
This model is consistent with the results that were described for
thrombin digestion of intact fibronectin. It is likely that thrombin
cleaves both the intact molecule and the 72,000 dalton fragment at the




NH2-TERMINAL ANALYSIS OF INTACT PLASMA FIBRONECTIN
AND SOME PROTEOLYTICALLY-DERIVED FRAGMENTS
Treatment with
L-Pyroglutamyl-peptide NH�terminal Residue NHz-terminal SequenceSubstrate Hydrolase y Dansylation on Automated Sequencer
Intact plasma None None
fibronectin
+ Ala Ala-Glx-Glx-Met-Val- (42%)a
230 and 235 kd Ala Ala-Ala-Val-Tyr- (52%)
thrombin
+ Not Done Not Done
fraS!!!ents
29 kd None None
thrombin
+ Ala Ala-Glx-Glx-Met-Val- (52%)fra ent
72 kd None Not Done
cathepsin D + Ala Ala-Glx-Glx-Met-Val- (59%)fra ent
43 kd Ala Not Done
cathepsin D/ + Ala Not Done
thrombin
fraS!!!ent
29 kd None Not Done




The values in parentheses represent the yields of alanine at the first step of























Figure 13. LOCATION OF THE GELATIN-BINDING REGION HITHIN
INTACT FIBRONECTIN
Note the relative positions of the 29 kd disulfide-enriched
fragment and the 43 kd region which contains one or more
gelatin-binding sites. Dashed lines indicate some of the
sites of fibronectin that are sensitive to cleavage by
thrombin or cathepsin D. Apparent molecular weights of some
of the fragments, as determined by SDS-polyacrylamide gel
electrophoresis under reducing conditions, are indicated by
numbers between horizontal arrows. As discussed in the text,




have identical electrophoretic mobilities (Fig. 10, I to K)�
Furthermore, the 230,000 and 235,000 dalton fragments and the
43,000 dalton fragment all bind to gelatin, and all have the same
NH2-terminal residue, alanine. However, the presence of relatively
large amounts of contaminants in the 29,000 dalton fragment sample
prepared by thrombin digestion of the 72,000 dalton piece (Fig. 101)
indicates that the 72,000 dalton fragment may contain some thrombin­
sensitive sites that are not exposed in the intact molecule.
Gold et al. (1979) have isolated a 50,000 dalton gelatin-binding
fragment from subtilisin digests of plasma fibronectin. The
NH2-terminal sequence of this fragment is Val-Tyr-Gln-Pro-Gln-Pro-His­
Pro-Gln-Pro-(Pro)-(Gly)-Tyr-Gly-His-( )-Val-. It is possible that
this sequence overlaps with that of the thrombin-derived 230,000 and
235,000 dalton fragments, Ala-Ala-Val-Tyr-. If so, the peptide bonds
cleaved by subtilisin and thrombin are separated by only two amino
acid residues.
It should be noted that the 43,000 dalton fragment described
above may not represent the only binding region for gelatin that
fibronectin contains. It is possible that there are additional sites
which are destroyed by protease digestion. However, gelatin-binding
fragments have been isolated from fibronectin following treatment with
a variety of proteases, including chymotrypsin (Hahn and Yamada, 1979a,
1979b), trypsin (Ruoslahti and Hayman, 1979; Ruoslahti et al., 1979),
and subtilisin (Gold et al., 1979); in each of these cases, only a
single binding region was demonstrated.
Analyses similar to those reported herein were not performed on
cellular fibronectin. However, Balian et ale (1979) have produced a
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gelatin-binding fragment by cathepsin D digestion of fibronectin
secreted by cultured amniotic fluid cells� This fragment had a
slightly higher apparent molecular weight than the 72,000 dalton
fragment derived from plasma fibronectin and migrated as a more
diffuse band on SDS-polyacrylamide gels (Balian et a1., 1979).
In addition, Hahn and Yamada (l979a) have found that chymotrypsin
digestion of both plasma and cellular fibronectins from chicken
gave rise to collagen-binding fragments of similar electrophoretic
mobilities. It seems likely, then, that cellular fibronectin has
a gelatin-binding region comparable to that of plasma fibronectin.
Therefore, the model depicted in Figure 13 is probably representative
of both forms of the molecule.
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Amino Acid Compositions of Intact Plasma Fibronectin and
Some Proteolytically-derived Fragments
The amino acid composition of human plasma fibronectin was
determined by standard techniques and is given in Table 2. The
composition shows no remarkable features and, as seen in Table 2,
is quite similar to those obtained by other laboratories (Mosesson
et al., 1975; Vuento et al., 1977; Iwanaga et al., 1978; Balian et
al., 1979; Gold et al., 1979). There are, however, two exceptions.
First, the content of cysteine is higher than previously reported.
Cysteine was quantitated follo,nng its conversion to cysteic acid by
performic acid oxidation of the protein. In the experiments described
herein, the oxidation reaction was quenched with HBr (}100re, 1963), a
procedure which prevents loss of cysteic acid by further oxidative
degradation. None of the other groups reported including such a
quenching step, which may account for their comparatively low yields
of cysteic acid. Second, the methionine content is lower than others
have found; this result will be discussed more fully below.
The amino acid compositions of the 43,000 dalton gelatin-binding
fragment and the 29,000 dalton fragment produced by thrombin cleavage
of intact fibronectin are given in Tables 3 and 4. When these
compositions, expressed as mole percentages of amino acids, are
compared with that of intact fibronectin, several differences are
apparent (Table 3). The 43,000 dalton fragment is relatively enriched
in glycine, cysteine, methionine, phenylalanine, and histidine. The




AMINO ACID COMPOSITION OF PLAS�� FIBRONECTIN
Other Investigators:
Humana,b c d e Human f HumangBovine Human Human
Amino Acid mol/molh mol i. {mol %2
Aspartic Acid 164 9.4 9.1 9.3 9.2 10.0 10.1
Threonine 195i 11. 1 i 9.8 9.7 10.7 10.0 10.4
Serine 142i 8.1 i 8.0 6.8 7.8 8.4 8.6
Glutamic Acid 206 11.8 11. 4 11. 6 11. 8 11.6 11.8
Proline 136 7.8 7.9 7.6 8.0 8.0 7.0
Glycine 148 8.5 9.1 8.0 9.1 8.8 8.3
Alanine 73 4.2 4.6 4.3 4.5 4.5 5.1
Cysteine + 55j 3. 1 j 2.0 2.6 2.2 2.0 2.1
Half-Cystine
Valine 138 7.9 7.6 8.1 7.8 7.9 6.0
Methionine 11 0.6 1.0 1.1 1.0 1.1 1.1
Isoleucine 79 4.5 4.3 4.4 4.4 4.6 3.1
Leucine 94 5.4 5.6 5.7 5.5 5.7 6.2
Tyrosine 76 4.3 4.0 4.5 4.1 4.8 4.3
Phenylalanine 43 2.5 2.2 2.7 2.5 2.9 2.6
Histidine 37 2.1 1.8 2.1 2.4 2.2 1.8
Lysine 59 3.4 3.9 3.6 3.6 3.8 4.4
Arginine 95 5.4 5.4 5.2 5.4 6.2 4.5
a
Tryptophan was not determined
b
Values are of triplicate analysesmeans
c
Iwanaga � al., 1978
d
Calculated from data of Mosesson � a L, , 1975
e
Balian � a1. , 1979
f
Gold � al., 1979
g Vuento � al., 1977
h
Calculated assuming �=250,000i
Calculated by extrapolation of values at 24 h, 48 h, and 72 h of hydrolysis
to 0 h





AMINO ACID COMPOSITIONS (mol %) OF I�TACT PLASMA FIBRONECTIN AND SOME
PROTEOLYTICALLY-DERIVED FRAGMENTSa
43 kd 29 kd
Intact
b Cathepsin D/Tgrombin b
Fibronectin Fragment Thrombin Fragment
Amino Acid {mol %2






9. Of (-19) 8.8e (-21)
Serine 8.1e 5.3g (-35) 6.5e (-20)
Glutamic Acid 11.8 12.9 (+ 9) 12.3 (+ 4)
Proline 7.8 4.9 (-37) 4.1 (-47)
Glycine 8.5 13.0 (+53) 12.6 (+48)
Alanine 4.2 3.4 (-19) 3.8 (- 9)
Cysteine + h 3.1 7.0 (+126) 8.8 (+184)
Half-Cystine
Valine 7.9 4.9 ( -38) 4.4 (-44)
Methionine 0.6 2.4 (+300) 1.2 (+100)
Isoleucine 4.5 2.2 (-51) 4.1 (- 9)
Leucine 5.4 3.7 (-31 ) 3.2 (-41 )
Tyrosine 4.3 3.3 (-23) 4.7 (+ 9)
Phenylalanine 2.5 4.2 (+68) 1.8 (-28)
Histidine 2. 1 4.8 (+129) 2.1 ( 0)
Lysine 3.4 2.8 (-18) 4.7 (+38)




Values the of triplicate analysesare means
c
Values the of duplicate analysesare means
d
Values in parentheses indicate the percentage of increase or decrease in
amino acid content when compared with the content in intact fibronectin







5% loss during 20 h hydrolysis (Moore and Stein, 1963)
10% loss during 20 h hydrolysis (Moore and Stein, 1963)
h





AMINO ACID COMPOSITIONS (mol/mol of protein) 'OF INTACT PLASMA FIBRONECTIN
AND SOME PROTEOLYTICALLY-DERIVED FRAGMENTSa
43 kd 29 kd
Intact
b Cathepsin D/Tgrombin d
Fibronectin Fragment Thrombin Fragment
Amino Acid (mol/mol of Erotein)
Aspartic Acid 164 34 17
Threonine 195e 27f 15e
Serine 142e 16g lIe
Glutamic Acid 206 39 21
Proline 136 15 7
Glycine 148 39 21.5
Alanine 73 10 6.5
Cysteine + h 55 21 15
Half-Cyst ine
Valine 138 15 7.5
Methionine 11 7 2
Isoleucine 79 7 7
Leucine 94 11 5.5
Tyrosine 76 10 8
Phenylalanine 43 13 3
Histidine 37 14.5 3.5
Lysine 59 8 8
Arginine 95 14 12
a
Tryptophan was not determined
b
Values are means of triplicate analyses and are calculated assuming �r=250,000
c
Values are means of duplicate analyses and are calculated assuming �= 43,000
d
Values are means of triplicate analyses and are calculated assuming �= 29,000
e
Determined by extrapolation of values at 24 h, 48 h, and 72 h of hydrolysis
to 0 h
f
Corrected for 5% loss during 20 h hydrolysis (Moore and Stein, 1963)
g Corrected for 10% loss during 20 h hydrolysis (Moore and Stein, 1963)
h




methionine, with lesser increases in lysine and arginine content.
The 43,000 dalton fragment is relatively poor in serine, proline,
valine, leucine, and isoleucine, whereas the 29,000 dalton fragment
is poor in proline, valine, leucine, and phenylalanine. For the
43,000 dalton fragment, the most striking changes are 2.3-fo1d
enrichments in histidine and cysteine, and a 4-fo1d increase in
methionine content. The 29,000 dalton fragment shows 2.8-fo1d and
2-fo1d enrichments in cysteine and methionine, respectively.
Both fragments, then, appear to be greatly enriched in
methionine. In fact, the two fragments combined contain almost all
of the methionine in the intact molecule (9 of 11 residues)
(Table 4). However, a closer examination of the data indicates that
this result may be an artifact. Methionine can be quantitated not
only directly, but also as the more stable methionine sulfone
derivative following performic acid oxidation. In the experiments
reported herein, methionine sulfone was eluted from the automated
amino acid analyzer column as a shoulder on the aspartic acid peak.
By taking the difference in areas under aspartic acid peaks from
comparable oxidized and untreated protein samples, an estimate of
the number of nanomo1es of methionine sulfone can be obtained. In
this way, it was estimated that the intact molecule contains about
35 residues of methionine per subunit chain. The 43,000 dalton and
29,000 dalton fragments contain approximately 9 residues and 1
residue, respectively. For the fragments, these estimates of
methionine content are about the same as obtained directly by analysis
of unoxidized protein samples. For the intact molecule, however,
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there is a 3-fold difference in the two sets of figures (35 residues
compared with 11 residues). Apparently, there was a variable loss
of methionine upon acid hydrolysis which was proportionately
greater for the intact molecule than for the fragments. Therefore,
the fragments are probably not enriched in methionine.
Both the 29,000 dalton and 43,000 dalton fragments contain
proportionately more cysteine than intact plasma fibronectin. Balian
et al. (1979) have reported that the 72,000 dalton cathepsin D-generated
fragment contains nearly all of the cysteine in the human plasma
fibronectin molecule. The data in Table 4, on the other hand, indicate
that the 43,000 dalton and 29,000 dalton fragments together contain
only about 65% of the total cysteine (36 of 55 residues). However,
these calculations are based on data expressed as moles of amino acid
per mole of polypeptide chain; as such, they reflect errors both in
the measurement of amounts of protein analyzed and in the estimation
of molecular weights of the proteins by SDS-polyacrylamide gel
electrophoresis. Therefore, although it is clear that the fragments
are enriched in cysteine, the fraction of the total cysteine found in
fibronectin that they contain is uncertain. Gold � al. (1979) have
reported similar enrichments in cysteine for 30,000 dalton and 50,000
dalton gelatin-binding fragments produced by subtilisin digestion of
human plasma fibronectin. Two fragments that are probably comparable
to the 29,000 dalton thrombin-derived fragment are also cysteine­
enriched: a 29,000 dalton fragment produced by plasmin cleavage of
hovine plasma fibronectin (Iwanaga et al. 1978) and a 25 000 dalton
--
, , ,
tryptic fragment of hamster cellular fibronectin (Wagner and Hynes, 1979).
 
76
The complete amino acid compositions of some of these fragments are
listed in Table 5.
Wagner and Hynes (1979) have demonstrated that cellular and
plasma fibronectins have only one or, at most, two free sulfhydryl
groups on each subunit chain; all other cysteine residues are
involved in disulfide linkages. Therefore, the 43,000 dalton and
29,000 dalton fragments must contain a large number of intrachain
disulfide bonds. As previously discussed, the presence of such
bonds in the 29,000 dalton fragment is also indicated by its
atypical migration in SDS-polyacrylamide gels under nonreducing
conditions. Although the 43,000 dalton fragment is almost as rich
in cysteine as the 29,000 dalton piece (7.0 mol % compared with 8.8
mol %), it has similar electrophoretic mobilities in both the
presence and absence of a reducing agent. Presumably, the
nonreduced 43,000 dalton fragment can assume a more extended





AMINO ACID COMPOSITIONS OF SOME PROTEOLYTICALLY-DERIVED PLASMA FIBRONECTIN
FRAGMENTS ISOLATED BY OTHER INVESTIGATORS
Gelatin-binding fragments
29 kd 72 kd 50 kd 30 kd
Plasmin Cathepsin D Subtilisin Subtilisin
Fragmenta Fragment' FragmentC FragmentC
Amino Acid (mol %) (mol %)
Aspartic Acid 10.0 11.1 13.0 13.7
Threonine 8.9 8.7 7.7 12.2
Serine 6.6 5.2 5.6 4.8
Glutamic Acid 12.8 13.6 13.6 12.6
Proline 4.4 4.6 4.4 4.1
Glycine 12.8 11.6 12.0 14.8
Alanine 4.2 3.2 3.5 2.9
Cysteine + 5.0 7.8 5.3 6.2
Half-Cystine
Valine 4.1 5.1 6.1 5.7
Methionine 1.9 2.5 2.3 2.8
Isoleucine 4.4 3.0 2.4 1.5
Leucine 4.2 3.1 4.8 4.3
Tyrosine 5.0 5.6 6.1 4.1
Phenylalanine 2.1 3.0 3.3 3.2
Histidine 2.0 3.6 4.0 3.8
Lysine 4.9 3.1 3.6 2.8
Arginine 6.7 5.0 4.0 3.8
a
Prepared from bovine plasma fibronectin by Iwanaga � a1., 1978
b
Prepared from human plasma fibronectin by Balian � a1., 1979
C
Prepared from human plasma fibronectin by Gold � a1., 1979
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A Possible Model of Fibronectin Structure
The results presented in this thesis determine the positions of
several proteolytic fragments within the intact plasma fibronectin
molecule. These data can be combined with results of other
investigators to construct a more detailed model of fibronectin.
Engvall et al. (1978) have investigated the ability of various
macromolecules to inhibit binding of fibronectin to gelatin. Collagen
and fibrinogen were able to interfere with this interaction, suggesting
that they bind to the same site on fibronectin as gelatin does.
Therefore, these molecules must also attach to fibronectin within the
43,000 dalton region.
Mosher et al. (1980) have used plasma transglutaminase (factor XIII )
-- a
to label human plasma fibronectin with a fluorescent substrate,
dansylcadaverine. The labeled molecule was then treated with various
proteases, and the digests were electrophoresed on SDS-polyacrylamide
gels to identify fragments containing the dansyl group. Following
cleavage of labeled fibronectin with thrombin, fluorescence was seen
only in the small fragment. Similar results have been obtained by
Jilek and Hormann (1977b), using trypsin digestion of fibronectin labeled
with (14C)putrescine and plasma transglutaminase. The transglutaminase-
sensitive glutamine residue of fibronectin must therefore be located
within the 29,000 dalton NH2-terminal region. As previously discussed,
plasma transglutaminase covalently cross-links plasma fibronectin to
collagen (Mosher et al., 1979), fibrin (Mosher, 1975), and other plasma
fibronectin molecules (Mosher, 1975); cellular fibronectin can be
cross-linked to high molecular weight cell surface complexes (Keski-Oja
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et al., 1976). It is noteworthy that covalent binding of fibrinogen
and collagen to fibronectin takes place within the 29,000 dalton
NH2-terminal peptide, but that noncovalent binding occurs within
the adjacent 43,000 dalton region. Mosher (1980) has speculated
that noncovalent interactions between these molecules and fibronectin
may be required to bring transglutaminase-reactive residues into
apposition.
Ruoslahti and Hayman (1979) have produced a group of gelatin­
binding fragments with molecular weights of approximately 70,000 by
trypsin digestion of human plasma fibronectin. More extensive
digestion yielded a 30,000 dalton gelatin-binding piece. These
gelatin-binding fragments did not promote attachment and spreading
of cells on plastic dishes, whereas fragments which lacked the
ability to bind to gelatin retained this activity. These results
suggest that gelatin-binding and cell-attachment sites are located
in different regions of fibronectin. Results of experiments by
Hahn and Yamada (1979b) lead to a similar conclusion and, furthermore,
allow the mapping of a cell attachment site. Hahn and Yamada have
isolated 160,000 dalton and 40,000 dalton fragments from chymotryptic
digests of chicken cellular fibronectin. The 160,000 dalton piece
did not bind to gelatin, but was able to promote hemagglutination
and cell spreading. In contrast, the 40,000 dalton fragment bound to
gelatin, but was inactive in the other two assays. The 160,000 dalton
fragment inhibited fibronectin-mediated cell attachment to collagen
when preincubated with the cells, but not when preincubated with the
collagen-coated substrate. Conversely, the 40,000 dalton fragment
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inhibited cell attachment only when preincubated with the collagen.
It appears, then, that the 160,000 dalton fragment binds to cells
but not to gelatin, whereas the 40,000 dalton gelatin-binding
fragment has no cell-binding activity. Since it has been
established that the 43,000 dalton gelatin-binding region is
separated from the NH2-terminus of intact fibronectin by a peptide
of only 29,000 daltons, the 160,000 dalton fragment must be derived
from a region located to the carboxyl side of the gelatin-binding
site. It is likely, therefore, that a cell surface-binding site of
fibronectin is located farther from the NH2-terminus of the molecule
than is the gelatin-binding site.
Gold et al. (1979) have isolated a 50,000 dalton subtilisin­
generated fragment of plasma fibronectin which both binds to gelatin
and promotes attachment of fibroblasts to collagen. As previously
discussed, NH2-terminal analysis of the 50,000 dalton and 43,000
dalton gelatin-binding fragments suggests that they may be generated
by cleavage of peptide bonds separated by only two amino acid
residues. If so, it follows that a cell attachment site must be
located either within the 43,000 dalton gelatin-binding region or
within a 7,000 dalton region adjacent to its carboxyl end.
Heparin does not inhibit binding of fibronectin to gelatin,
indicating that heparin and gelatin interact with different sites
on the molecule (Engvall and Ruoslahti, 1977). In accordance with
this finding, Yamada et al. (1980) have discovered that only the
160,000 dalton chymotryptic cellular fibronectin fragment binds to
heparin-Sepharose. In a preliminary experiment, both the small and
the large thrombin-generated fragments were bound by heparin-Sepharose.
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Further experimentation will be required to resolve this
discrepancy.
Wagner and Hynes (1979) have labeled hamster cellular
fibronectin with (3H)glucosamine. Subsequent digestion with
trypsin produced an unlabeled, disulfide-enriched 25,000 dalton
fragment and a labeled 200,000 dalton fragment. Since this
25,000 dalton fragment is probably comparable to the 29,000
dalton thrombin-generated fragment, it appears that none of the
carbohydrate chains of fibronectin is located in the NH2-terminal
region. Takasaki et al. (1979) have shown that bovine plasma
fibronectin contains an average of three asparagine-linked sugar
chains per subunit; hamster cellular fibronectin contains five or
six chains per subunit (Carter and Hakomori, 1979). However, the
distribution of these chains between the subunits and among the
various proteolytically-derived fragments is not known. The
gelatin-binding fragments isolated by Ruoslahti et al. (1979) are
probably glycosylated, since they were bound by concanavalin
A-Sepharose. Preliminary reports of experiments involving
proteolytic cleavage of fibronectin labeled with radioactive sugars
also indicate that the gelatin-binding region contains at least one
carbohydrate chain (Balian et al., 1979; Hahn and Yamada, 1979a).
Wagner and Hynes (1980) have determined, using DTNB, that
plasma and cellular fibronectins contain one or two cysteine
residues in each subunit chain. As previously described, treatment
of cellular fibronectin with DTNB and subsequent cleavage at modified
cysteine residues with (14C)cyanide yielded fragments of 170,000
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daltons and 33,000 daltons (Wagner and Hynes, 1980). The 170,000
dalton fragment was not labeled with l4C, and is therefore located
at the NH2-terminal end of the intact molecule. Thus, a sulfhydryl
group is located immediately adjacent to the carboxyl end of the
170,000 dalton region, approximately two-thirds of the linear
distance from the NH2-terminus of intact fibronectin. Since the
170,000 dalton and 33,000 dalton fragments do not account for the
entire fibronectin molecule, Wagner and Hynes (1980) have suggested
that there may be a second cysteine residue, or perhaps a particularly
labile cystine group, located somewhat farther from the NH2-terminus.
Cleavage at this site would give rise to the 33,000 dalton fragment,
as well as another peptide which was not detected in these experiments.
Treatment of cellular fibronectin with N-ethylmaleimide or
iodoacetic acid, in the absence of a reducing agent, destroys its
ability to bind to monolayers of hamster cells (Wagner and Hynes, 1979),
suggesting that the sulfhydryl groups play a role in interaction with
cell surface components. However, as mentioned, analysis of a
subtilisin fragment of plasma fibronectin (Gold et al., 1979) indicates
that a site which interacts with cells to promote their attachment to
collagen is located closer to the NH2-terminus, perhaps within the
43,000 dalton gelatin-binding region or an adjacent 7,000 dalton
region. It may be, then, that cells interact with different sites on
the fibronectin molecule in these two assays. However, it should be
noted that the fragment described by Gold et al. (1979) is much less
active than intact fibronectin in promoting cell attachment. In
contrast, the 160,000 dalton fragment described by Hahn and Yamada
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(1979b), which must contain at least one of the sulfhydryl groups,
is nearly as active as the whole molecule when tested in two
different cell adhesion assays.
The results of this thesis research thus allow the positioning
of several sites of biological interest within the fibronectin
molecule, as summarized in Figure 14. Although some findings have
not been confirmed for" both cellular and plasma fibronectins, all
available evidence indicates that the two forms are quite similar
with respect to the structural features that have been discussed.
Clearly, many important questions regarding the structure of
fibronectin remain unanswered. For instance, the location of the
interchain disulfide bonds has not been demonstrated conclusively,
and the structural basis for the functional differences between
cellular and plasma fibronectins is still uncertain. Studies
involving further fragmentation of fibronectin may answer these and
similar questions and will lead to more detailed models of the
molecule. Such models will serve as a basis for further
experimentation, and may eventually contribute to a better
understanding of how plasma and cellular fibronectins act in vivo
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Figure 14. A POSSIBLE MODEL OF FIBRONECTIN STRUCTURE
As discussed in detail in the text, results of this thesis research were
combined with those of experiments by others to determine the approximate
locations of several features of interest within the intact fibronectin
molecule, including binding sites for other macromolecules and cell
surfaces. Dashed lines denote approximate sites of cleavage by various
proteases; approximate molecular weights of some fragments so produced
are indicated by numbers between horizontal arrows. The 29 kd and 43 kd
regions are enriched in intrachain disulfide bonds, but the numbers and
locations of these bonds within each fragment are not known. The
assignment of the interchain disulfide bonds to a COOH-terminal region
is tentative. A second cysteine residue may be located to the carboxyl
side of the residue which is depicted. Plasma fibronectin contains an
average of 3 carbohydrate chains per subunit; cellular fibronectin may
contain 5 or 6 chains per subunit. The 29 kd region probably contains
no carbohydrate, whereas the 43 kd region probably contains at least one
chain. The distribution of carbohydrate chains between the subunits and
among the various fragments is otherwise unknown. Binding sites for
heparin and cell surfaces are located to the carboxyl side of the
gelatin-binding site, but the possibility that they lie within the 43 kd
region has not been ruled out. There is some evidence that suggests
that there are mUltiple binding sites for heparin and cell surfaces;
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